Top

Pamela T. Soliman, M.D., M.P.H.

Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery

About Dr. Soliman

Dr. Pamela T. Soliman is a Professor in the Department of Gynecologic Oncology and Reproductive Medicine at MD Anderson Cancer Center. Dr. Soliman is the ad interim Chair of the department and the Fellowship Program Director. She is board certified in Gynecologic Oncology. She provides both medical and surgical care to women with gynecologic cancers. Dr. Soliman has a special interest in minimally invasive surgery. She currently performs minimally invasive surgery for appropriate patients with cervical, endometrial, and early-stage ovarian cancers as well as fertility-sparing procedures for young women with cervical cancer.

Dr. Soliman’s primary research interests are in the treatment of endometrial cancer. This includes primary surgical staging as well as treatment for recurrent disease. She has completed prospective trials evaluating sentinel lymph node mapping and PET/CT imaging in high risk endometrial cancer. She is also the PI of a number of clinical trials evaluating treatment for recurrent and advanced endometrial cancer including novel therapies. Her interest in surgical outcomes includes protocols evaluating the role of minimally invasive surgery and sentinel lymph node mapping, as well as quality of life and surgical outcomes for patients who are treated with pelvic exenteration for recurrent cancer. She has authored and co-authored numerous articles in peer-reviewed journals on these and other subjects. In addition, she has been invited to write book chapters and review articles on a variety of topics in gynecologic oncology. Dr. Soliman is an active speaker, both nationally and internationally.

Dr. Soliman is a fellow of the American College of Obstetricians and Gynecologists, and a member of the American Society of Clinical Oncology, the Society of Gynecologic Oncologists and the American Association of Gynecologic Laparoscopists (AAGL). Dr. Soliman also serves as a reviewer for several journals including Journal of Clinical Oncology, Gynecologic Oncology, International Journal of Gynecologic Cancer, and Journal of Minimally Invasive Gynecology.

Undergraduate School: B.A. Mathematics, Duke University, Durham, NC 1995

Medical School: M.D., Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, 1999

Residency: Obstetrics/Gynecology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, 1999 - 2003

Fellowship: Gynecological Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 2003-2007

Graduate School: M.P.H., University of Texas School of Public Health, Houston Texas, 2006.

Years at MD Anderson: Since 2003

Meet Pamela Soliman, M.D.

In the News

Illustration of a bald patient receiving chemotherapy

What is chemoradiation? 

Cancerwise blog post: ovarian cancer symptoms women shouldn't ignore.

Ovarian cancer symptoms: 4 things to know

Close-up waist view of woman's hands holding her abdomen due to ovary pain associated with ovarian cancer.

What does ovarian cancer pain feel like?

Present Title & Affiliation

Primary Appointment

ad interim Department Chair, Department of Gynecologic Oncology & Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

Endowed Professor Mattie Allen Fair Professorship in Cancer Research, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

ad interim Chair, Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

Mattie Allen Fair Professorship in Cancer Research, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Deputy Chair, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Volunteer Faculty, Lyndon Baines Johnson Hospital, Houston, TX

Education & Training

Degree-Granting Education

2006	The University of Texas Health Science Center Houston, School of Public Health, Houston, Texas, US, Thesis "Knowledge of weight and endometrial cancer: What women know", MPH
1999	Medical College of Virginia, Richmond, Virginia, US, MD
1995	Duke University, Durham, North Carolina, US, Mathematics, BA

Postgraduate Training

2020-2020	MD Anderson Leadership Institute, LEADing Teams – Accelerate Program, Harvard Business Publishing Corporate Learning, Houston, Texas
2019-2019	Women's Leadership Forum, University of Texas, Houston, Texas
2016-2017	Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, Texas
2013-2013	Leadership Development, Value Measurement for Health Care, Harvard Business School, Boston, Massachusetts
2003-2007	Fellowship, Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
1999-2003	Internship and Residency, Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, Virginia

Licenses & Certifications

2010	American Board of Obstetrics and Gynecology, Gynecologic Oncology
2009	American Board of Obstetrics and Gynecology
2005	State of Texas
2000	Commonwealth of Virginia

Experience & Service

Faculty Academic Appointments

Fellowship Program Director, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - 2024

Inpatient Executive Medical Director, Department of VPs Office, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2023

Center Medical Director, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2020

Associate Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2018

Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2012

Administrative Appointments/Responsibilities

Fellowship Program Director, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present

Deputy Chair, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present

Fellowship Program Assistant Director, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2017

Co-Director, Department of Minimally Invasive New Technology in Oncologic Surgery Education Task Force, Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - Present

Team Leader, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center/Patient Care and Operations Team, Houston, TX, 2008 - 2013

Chief Administrative Fellow, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2006 - 2007

Administrative Chief Resident, Department of Obstetrics and Gynecology, Medical College of Virginia, Richmond, VA, Richmond, VA, 2002 - 2003

Other Professional Positions

Member of Board of Directors, Society of Gynecologic Oncology, 2024 - Present

Committee Member, Society of Gynecologic Oncology Clinical Practice Committee, N/A, 2020 - 2021

Program Committee Member, International Gynecologic Cancer Society Annual Meeting, Chicago, IL, 2019

Chair, AAGL General Grants for MIGS Research Committee, Cypress, CA, 2018

Committee Member, AAGL Diversity & Inclusion Committee, Cypress, CA, 2018 - Present

Committee Member, SGO 2018 Program and Steering Committee, National Harbor, MD, 2017 - 2018

Member of Editorial Board, Journal of Minimally Invasive Gynecology Editorial Board, Philadelphia, PA, 2017 - Present

Committee Member, ASCO clinical practice committee - SGO representative, Houston, TX, 2017 - Present

President, Felix Rutledge Society, Houston, TX, 2017 - 2019

Committee Member, AAGL Clinical Research Seminar Grant Committee, Cypress, CA, 2017

Chair, AAGL General Grants for MIGS Research Committee, Cypress, CA, 2017

Committee Member, AAGL Scientific Program Committee, Houston, TX, 2016 - 2017

Committee Member, AAGL Clinical Research Seminar Grant Committee, Houston, TX, 2016 - 2019

Chair, AAGL General Grants for MIGS Research Committee, Houston, TX, 2016

Committee Member, MDA Medical Quality Planning Committee, Houston, TX, 2015 - 2016

Treasurer, Felix Rutledge Society, Houston, 2013 - 2016

Tissue Extraction Task Force, Advancing Minimally Invasive Gynecology Worldwide, Washington, DC, 2013

Committee Member, MDA Department of Gynecologic Oncology Ovarian Cancer QI Committee, Houston, TX, 2013 - Present

Council Member, Felix Rutledge Society, Houston, TX, 2012 - 2013

Member, Board of Directors, Judith Liebenthal Robinson Ovarian Cancer Foundation, Houston, TX, 2011 - Present

Extramural Institutional Committee Activities

Division of Surgery Elected Representative, PRS Budget & Finance Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present

Member, Executive Billing and Compliance Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present

Division of Surgery Representative, PRS Clinical Revenue Cycle Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present

Committee Member, New Vice Provost-CR Working Group: "Enhancing Industry Partnerships", The University of Texas MD Anderson Cancer Center, 2013 - 2014

Committee Member, Surgical Series Advisory Committee (SSAC), The University of Texas MD Anderson Cancer Center, 2013

Member, Data Safety Monitoring Board, The University of Texas MD Anderson Cancer Center, 2012 - 2013

Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2010 - 2012

Member, Developmental Therapeutics Research Group, Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2010 - Present

Member, Prevention Research Group, Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, 2010 - Present

Member, Pharmacy and Therapeutics Committee, The University of Texas, M.D. Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2008 - 2013

Executive Committee Member, Minimally Invasive and New Technologies in Oncologic Surgery (MINTOS), The University of Texas M.D. Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2007 - Present

Member & Co-Chair, Innovative Surgery Working Group, Department of Gynecologic Oncology, Division of Surgery, The University of Texas M.D. Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2007 - Present

Member, Operating Room Committee, The University of Texas, M.D. Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2007 - 2016

Member, Psychosocial, Behavioral and Health Services Research Committee, The University of Texas, M.D. Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2007 - 2011

Fellow Member, Institutional Review Board,The University of Texas, M.D. Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2004 - 2005

Member, Fellowship Planning Committee, The University of Texas , M.D. Anderson Cancer Center, Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, 2004 - Present

Member, Fellowship Admissions Sub-Committee, The University of Texas, M.D. Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2004 - Present

Member, Graduate Medical Education Committee, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, The University of Texas MD Anderson Cancer Center, 2003 - 2008

Member, House Staff Council, Medical College of Virginia, The University of Texas MD Anderson Cancer Center, 2000 - 2003

Member, Honor Council, Medical College of Virginia, The University of Texas MD Anderson Cancer Center, 1998 - 1999

Editorial Activities

Editorial Board Member, Journal of Minimally Invasive Gynecology, 2017 - Present

Editorial Board, Journal of Women's Health and Gynecology, 2014 - Present

Honors & Awards

2022	Thomas H. and Mayme P. Scott Fellowship in Cancer Research, The University of Texas MD Anderson Cancer Center
2021	RSNA 2021 Education Exhibit Award, Radiological Society of North America
2020	Top OBGYN in Houston, TX 2020, Texas Magazine
2019 - 2020	2020 Top Reviewers for the International Journal of Gynecological Cancer, International Journal of Gynecological Cancer
2019	Education Week Educator Award, The University of Texas MD Anderson Cancer Center
2019	The University of Texas MD Anderson Cancer Center Distinguished Educator Award, The University of Texas MD Anderson Cancer Center
2017	JMIG Editorial Board Best Reviewer Award, AAGL
2017	Judy's Mission Annual Luncheon Honoree
2016	President's Recognition of Faculty Excellence Honoree, The University of Texas MD Anderson Cancer Center
2015	Celebrating Improvement at MD Anderson Recognition for ACT+ Project, The University of Texas MD Anderson Cancer Center
2015	Regents Outstanding Teaching Award, University of Texas System
2014	Certificate of Appreciation for Humanitarian Services, Medical Surgical Mission at Culasi-Pandan, Antique, Philippines
2011	APGO Excellence in Teaching Award, Department of Obstetrics & Gynecology, The University of Texas MD Anderson Cancer Center
2011	Cattlemen for Cancer Research Hero Award, Cattlemen for Cancer Society
2011	McDonogh School Athletic Hall of Fame, McDonogh School, Owings Mills, Maryland
2008 - 2009	Candidate Representative, Society of Gynecologic Oncologists Council
2007	Jesse H. Jones Fellowship in Cancer Education, The University of Texas M.D. Anderson Cancer Center
2005	2005 Daniel Roberts Award, American College of Obstetrics and Gynecology District VII and VIII Annual meeting
2005	Fellows Travel Grant, American Society of Clinical Oncology (ASCO)
2005	National Gynecologic Oncology Fellows Forum Award
2004	The M.D. Anderson Alumni and Faculty Association Travel Award, UT MD Anderson Cancer Center, Houston, Texas
2003	Department of OB/Gyn, Resident Research Award, Medical College of Virginia, Richmond, Virginia
2003	The Lucent Wood and Ida Talley Roberts Award, Medical College of Virginia, Richmond, Virginia
1993 - 1995	Golden Key Honor Society
1993 - 1995	National Collegiate Athletic Association Academic All-American, Duke University, 1993-1995, NCAA
1993 - 1995	National Collegiate Athletic Association Scholarship Athlete, Duke University Golf Team
1993 - 1995	Phi Beta Sigma Honors Society

Professional Memberships

Advances in Robotic and Minimally Invasive Surgery in Gynecology

2019

The University of Texas MD Anderson Cancer Center Academy of Health Science Education

2019 - Present

UT MD Anderson Cancer CenterAnnual Uterine Cancer Biology Symposium Planning Committee

2012 - Present

Houston Gynecological & Obstetrical Society

2011 - Present

Harris County Medical Society

2007 - Present

American Association of Gynecologic Laparoscopists

2007 - Present

Texas Medical Association

2007 - Present

Felix Rutledge Society

2007 - Present

Society of Gynecologic Oncology

2005 - Present

American College of Surgeons

2005 - Present

American Society of Clinical Oncology

2003 - Present

American Association for Cancer Research

2003 - Present

American College of Obstetrics and Gynecology

1999 - Present

American Medical Association

1995 - 1999

American Medical Student Association

1995 - 1999

Selected Presentations & Talks

Local Presentations

2023. What You Need to Know About Ovarian Cancer. Conference. Houston Health Department. Houston, TX, US.
2022. Surgical Management of Endometrial Cancer and Potential Complications. Conference. MD Anderson Cancer Center. Houston, TX, US.
2022. Advanced Care Planning. Conference. MD Anderson Cancer Center. Houston, TX, US.
2022. MINTOS Update. Conference. MD Anderson Cancer Center. Houston, TX, US.
2015. Evolution of mTOR Targeting in Endometrial Cancer. Conference. Advances in Oncology Institutional Grand Rounds - UT MD Anderson Cancer Center. Houston, TX, US.
2015. Lit Review. Conference. Gynecologic Oncology Didactic Series Conference. Houston, TX, US.
2014. Surgical Curriculum-Upper Abdominal Surgery. Conference. Gynecologic Oncology Didactic Series Conference. Houston, TX, US.
2014. Surgical Curriculum - Bowel Surgery. Conference. Gynecologic Oncology Didactic Series Conference. Houston, TX, US.
2014. Surgical Curriculum Series - Groin. Conference. Gynecologic Oncology Didactic Series Conference. Houston, TX, US.
2014. Surgical Curriculum Series - Flaps. Conference. Gynecologic Oncology Didactic Series Conference. Houston, TX, US.
2014. Management of Early Stage Cervical Cancer and Surgical Curriculum Series - Urinary Diversions. Conference. Gynecologic Oncology Didactic Series Conference. Houston, TX, US.
2014. Radical Hysterectomy plus Trachelectomy. Conference. Gynecologic Oncology Didactic Series Conference. Houston, TX, US.
2013. Career Development - Finding a Job. Conference. Gynecologic Oncology Didactic Series Conference. Houston, TX, US.
2013. Minimally Invasive Procedures. Conference. Gynecologic Oncology Didactic Series Conference. Houston, TX, US.
2013. Primary Management of Endometrial Cancer - Sentinel Lymph Node Mapping and LND. Conference. Gynecologic Oncology Didactic Series Conference. Houston, TX, US.
2013. Periop Management. Conference. Gynecologic Oncology Didactic Series Conference. Houston, TX, US.
2013. Fertility Preservation in the Cancer Survivor. Conference. The Woman's Hospital of Texas, Texas Clinical Symposium on Women's Health. Houston, TX, US.
2012. The Truth About Ovarian Cancer: What Women Should Know About the Signs and Symptoms. Conference. JLR Foundation: The Women's Fund for Health Education and Research. Houston, TX, US.
2011. Postoperative Complications. Conference. Gynecologic Oncology Department-UT MD Anderson Cancer Center. Houston, TX, US.
2011. Upper Abdominal Surgery. Conference. Gynecology Oncology Department - UT MD Anderson Cancer Center. Houston, TX, US.
2011. Urinary Conduits. Conference. Gynecologic Oncology Department - UT MD Anderson Cancer Center. Houston, TX, US.
2011. Reconstruction at Pelvic Exenteration. Conference. Gynecologic Oncology Department - UT MD Anderson Cancer Center. Houston, TX, US.
2011. Radical Hysterectomy. Conference. Gynecologic Oncology Department - UT MD Anderson Cancer Center. Houston, TX, US.
2010. Bowel Surgery. Conference. Gynecologic Oncology Department - UT MD Anderson Cancer Center. Houston, TX, US.
2010. OR Positioning. Conference. Gynecologic Oncology Department - UT MD Anderson Cancer Center. Houston, TX, US.
2010. Postoperative Care In Exenteration Patients. Conference. Gynecologic Oncology Department-UT MD Anderson Cancer Center. Houston, TX, US.
2010. Procedures. Conference. Gynecologic Oncology- UT MD Anderson Cancer Center. Houston, TX, US.
2010. Instruments & Sutures. Conference. Gynecologic Oncology Department - UT MD Anderson Cancer Center. Houston, TX, US.
2009. Endometrial Cancer and Obesity: What women know. Conference. Texas Laparoscopic Consultants. Houston, TX, US.
2007. Minimally Invasive Surgery in Gynecologic Oncology. Conference. Minimally Invasive and New Technologies in Oncologic Surgery. Houston, TX, US.
2007. Screening for Gynecologic Cancers. Conference. Porter and Hedges. Houston, TX, US.
2005. Adiponectin and Endometrial Cancer. Conference. M.D. Anderson Cancer Center. Houston, TX, US.

Regional Presentations

2022. Update endometrial cancer guidelines. Conference. Mayo Clinic. Rochester, NY, US.
2022. Introduction of molecular analysis into clinical practice. Conference. Mayo Clinic. Rochester, NY, US.
2020. Women's Initiative Annual Health Series: Ovarian Cancer. Conference. Holland & Knight, US.
2020. Surgical Safety, Testing and Triage Considerations During the COVID-19 Pandemic. Conference. Sociey of Gynecologic Oncology. Webinar, Webinar, US.
2014. Surgical Curriculum - Upfront Management of Endometrial Cancer. Conference. Gynecologic Oncology Didactic Series Conference. Houston, US.
2014. Annual MINTOS Surgical Education Course. Conference. Division of Surgery Grand Rounds. Houston, US.
2014. Surgical Anatomy Board Review. Conference. Gynecologic Oncology Didactic Series Conference. Houston, US.
2014. Surgical Curriculum Series - Post-Operative Complications. Conference. Gynecologic Oncology Didactic Series Conference. Houston, US.
2014. The Pelvic Mass: Strategies. Conference. University of Texas Galveston. Galveston, TX, US.
2003. Urinary symptoms in an inner city population: Are we addressing them during annual examination?. Conference. Medical College of Virginia. Richmond, VA, US.
2003. Laparoscopic Approach to the Adnexal Mass. Conference. Medical College of Virginia. Richmond, VA, US.
2003. Vaginal Vault Prolapse. Conference. Medical College of Virginia. Richmond, VA, US.

National Presentations

2025. Clinicopathological features and survival outcomes in women with endometrial neuroendocrine tumors. Poster. 2025 ASCO Annual Meeting. Chicago, Illinois, US.
2025. Spatial transcriptomic profiling from over 300 leiomyosarcoma samples. Invited. 2025 ASCO Annual Meeting. Chicago, Illinois, US.
2025. Clinicopathologic characteristics and survival outcomes in women with endometrial neuroendocrine tumors. Poster. 2025 WAGO Annual Meeting. Colorado Springs, Colorado, US.
2025. Leiomyosarcoma is characterized by two distinct subtypes driven by NFI or AP1 transcription factors. Poster. AACR Annual Meeting 2025. Chicago, Illinois, US.
2025. The Best of 2024: Practice Changing Trails/Results. Panelist. Felix Rutledge Society- 21st Oncology Update: Advances and Controversies. Steamboat Springs, Colorado, US.
2024. Hormonal and Biomarker therapy for endometrial cancer. Conference. Felix Rutledge Society Annual Mee ng. Fort Lauderdale, FL, US.
2023. Exploring the utility of liquid biopsy (ctDNA) as a translational endpoint in clinical trials for endometrial cancer. Invited. 2023 SGO Annual Meeting. Tampa, FL, US.
2022. Distillation Talk. Conference. SGO 2022 Annual Meeting. Phoenix, AZ, US.
2020. Understanding Anterior Parametrectomy for Preventing Local and Pelvic Recurrences in Cervical Cancer - an Answer to Failure of LACC Trial. Conference. 49th AAGL Global Congress on Minimally Invasive Gynecology.
2019. Surgical Care of Uterine Leiomyosarcoma. Invited. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2019. Objectives of the Cadaver Lab. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2019. Speed mentoring – Mentor for career satisfaction – how to decide between an academic and private practice. Conference. Society of Gynecologic Oncology. Honolulu, HI, US.
2019. Sentinel lymph node mapping in endometrial cancer, impact on adjuvant treatment decisions. Invited. Society of Gynecologic Oncology. Honolulu, HI, US.
2019. Sentinel nodes and adjuvant management based on sentinel nodes. Invited. Education Forum III: Endometrial Tumors - Controversies in Adjuvant Therapy?. Honolulu, HI, US.
2018. Clinical Seminar - Approach to the Pelvic Mass. Invited. ACOG. Austin, TX, US.
2017. Pelvic Mass. Invited. American College of Obstetrics and Gynecology. San Diego, CA, US.
2017. Tubes and Ovaries: Should They Stay or Should They Go?. Invited. Chair AAGL Subspecialty Session. San Diego, CA, US.
2017. Strategies to Avoid the Chance Encounter with a Gyn Malignancy. Invited. Chair AAGL Subspecialty Session. San Diego, CA, US.
2016. The Best of 2025: Practice Changing Trials/Results - Gynecological Oncology. Invited. 22nd Oncology Update: Advances and Controversies. Houston, Texas, US.
2016. Pelvic Mass. Invited. American College of Obstetrics and Gynecology. Washington, DC, US.
2015. Robotic Hysterectomy. Invited. Johns Hopkins University. Baltimore, MD, US.
2015. The Pelvic Mass: Strategies for Providing Optimum Care and Avoiding Nasty Surprises. Invited. American College of Obstetricians and Gynecologists. San Francisco, CA, US.
2015. Poster:Paraneoplastic Neurological Syndrome in Ovarian Carcinoma. Conference. Society of Gynecologic Oncology. Chicago, IL, US.
2015. Poster:Platinum-Free Interval in a predictor of survival for recurrent, advanced stage uterine papillary serous carcinoma. Conference. Society of Gynecologic Oncology. Chicago, IL, US.
2014. Robotic Operating Room: Positioning, Docking, Trendelenburg, Trocars, Efficiency. Invited. UT MD Anderson Cancer Center, Robotic Advances in Gynecology, 3M Conference. Houston, TX, US.
2014. Endometrial Cancer and Sentinel Lymph Node Mapping. Invited. UT MD Anderson 44th Annual Meeting of the Felix Rutledge Society. Scottsdale, AZ, US.
2013. Evaluation of Laparoscopic Extra-peritoneal Para-aortic Lymphadenectomy vs Trans-peritoneal Laparoscopic or Robotic Para-aortic Lymphadenectomy for Endometrial Cancer Staging. Invited. AAGL Global Congress on Minimally Invasive Gynecology. National Harbor, MD, US.
2013. Ovarian Cancer Screening and Early Detection. Invited. Foundation for Women's Cancer. Morristown, NJ, US.
2013. Obesity in Endometrial Cancer. Invited. UT MD Anderson 43rd Annual Meeting of the Felix Rutledge Society. San Juan, Puerto Rico, US.
2013. The Pelvic Mass: Strategies for Providing Optimum Care and Avoiding Nasty Surprises. Invited. ACOG 61st Annual Clinical Meeting. New Orleans, LA, US.
2012. Ovarian Cancer Prevention and Screening. Invited. Medical College of Virginia. Richmond, VA, US.
2012. Hereditary Cancer Syndromes in Gynecologic Oncology. Invited. Medical College of Virginia. Richmond, VA, US.
2012. Managing the Unexpected Ovarian Malignancy. Invited. Gate Institute 19th Annual Gynecologic Surgery and Oncology Conference. Cambridge, MD, US.
2012. Ovarian Cancer Prevention and Screening. Invited. Gate Institute 19th Annual Gynecologic Surgery and Oncology Conference. Cambridge, MD, US.
2012. Biomarkers of Obesity: The Adiponectin Story. Invited. 2012 Annual Meeting on Women's Cancer. Austin, TX, US.
2011. Adipokines and Risk for Endometrial Cancer. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
2011. Surgical Challenges in the Obese Patient. Invited. 41st Annual Felix Rutledge Society Conference. Houston, TX, US.
2010. Optimizing OR Set-Up in Laparoscopy and Robotics. Invited. AAGL Annual Conference. Las Vegas, NV, US.
2010. Robotic Surgery in Modern Gynecology. Invited. American College of Obstetrics and Gynecology. Baltimore, MD, US.
2010. Hereditary Cancers in Gynecologic Oncology. Invited. Carroll Hospital Grand Rounds. Baltimore, MD, US.
2009. Robotic Simple Hysterectomy. Invited. AAGL Annual Conference. Orlando, FL, US.
2009. Robotic Surgery in Gynecologic Oncology. Invited. Society of Gynecologic Nursing Oncology. Orlando, FL, US.
2009. Update in Robotic Surgery for Gynecologic Oncology. Invited. Pan American Robotic Oncology Symposium. Houston, TX, US.
2009. Developing a Prospective Robotic Database. Invited. Pan American Robotic Oncology Symposium. Houston, TX, US.
2009. Adiponectin and Endometrial Cancer. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
2005. Adiponectin as a Marker for Insulin Resistance and Endometrial Cancer Risk. Invited. Annual Meeting of the Society of Gynecologic Oncology. Miami, FL, US.
2005. Adiponectin as a Marker for Insulin Resistance and Endometrial Cancer Risk. Invited. National Gynecologic Oncology Fellows' Forum. Tucson, AZ, US.
2004. Synchronous Primary Cancers of the Endometrium and Ovary: A Single Institution Review of 84 Cases. Invited. GlaxoSmithKline National Gynecologic Oncology Fellows' Forum. San Diego, CA, US.

International Presentations

2025. Debate 01: Adjuvant Therapy Guided by Molecular Classification Is Essential to Improve Outcomes for Patients with Endometrial Cancer. Invited. IGCS 2025 Annual Global Meeting. Cape Town, ZA.
2025. Clinical and Biomarker Results From E7386 Study 102: Global Dose-Expansion Cohort of E7386 + Lenvatinib in Patients With Advanced/Recurrent Endometrial Cancer That Progressed on Platinum-Based Chemotherapy and an Anti−PD-(L)1 Immunotherapy. Poster. 2025 European Society for Medical Oncology Annual Meeting. Berlin, DE.
2022. Poster Rounds with the Professors. Invited. IGCS 2022. New York, US.
2022. Exploring The Role Of Molecular Aberrations In Predicting Response To Everolimus In The Treatment Of Endometrial Cancer. Conference. IGCS 2022. New York, US.
2022. Standardized documentation of advanced care planning to facilitate goal-concordant care in a large gynecologic oncology practice. Conference. 2022 ASCO Annual Meeting. Chicago, US.
2021. Hematology/Oncology Utilization of Advance Care Planning. Conference. American Society of Clinical Oncology. Boston.
2021. Uterine Sarcomas: Considerations for Treatment. Invited. Moscow 2021 2nd international Web Conference. Moscow.
2019. Who Are Candidates for Genetic Testing and Risk-Reducing Surgery?. Invited. 47th AAGL Global Congress on Minimally Invasive Gynecology. Vancouver, CA.
2019. Faculty- Oral poster Discussion Session. Invited. IGCS 2019 Global Meeting of the International Gynecologic Cancer Society. Rio De Janeiro, BR.
2019. Perioperative anticoagulation in Gynecologic Oncology. Invited. IGCS 2019 Global Meeting of the International Gynecologic Cancer Society. Rio De Janeiro, BR.
2019. Current Management of Early Cervical Cancer. Invited. Hunan Province Anti-Cancer Association. Changsha, CN.
2018. Sentinel Lymphnode, Lymphadenectomy or No Lymphadenctomy in Endometrial Cancer. Conference. IGCS. Kyoto, JP.
2017. Sentinel Lymph Node mapping and Endometrial Cancer. Invited. AAGL. Beijing, CN.
2017. Sentinel lynph node mapping for endometrial cancer. Invited. AAGL International Congress on minimally invasive Gynecology. Cartagena, CO.
2017. Fertility conservation surgery for cervical cancer. Invited. AAGL International Congress on minimally invasive Gynecology. Cartagena, CO.
2017. Systematic approach to advanced ovarian cancer: MD Anderson algorithm. Invited. AAGL International Congress on minimally invasive Gynecology. Cartagena, CO.
2016. Ovarian Cancer: A Woman's Nightmare. Invited. Association of Philippine Physicians in Maryland, Inc. Stevenson, US.
2014. The Robotic Simulator: Setting Benchmarks for the New User. Invited. AAGL Global Congress on Minimally Invasive Gynecology. Vancouver, CA.
2014. Scientific Virtual Poster: Positioning Injury in Robotic Gynecologic Surgery. Invited. AAGL Global Congress on Minimally Invasive Gynecology. Vancouver, CA.
2014. Clinical Science Symposium:Finding the Targets in Gynecologic Cancers. Invited. ASCO. Chicago, US.
2014. New Approaches to Upfront Management of Endometrial Cancer. Invited. The Second Hunan Provincial Forum on Gynecology Oncology, The Annual Conference of the Cervical Cancer Prevention and Cure Committee of Hunan Provincial Female Doctors Association, 2014. Changsha Hunan, CN.
2012. Robotic and Laparoscopic Technique: Tips and Tricks in Obese Patients - How to Close Vaginal Cuff to Avoid Dehiscence. Invited. AAGL Advancing Minimally Invasive Gynecology Worldwide. New York, US.
2012. Bladder and Ureter Injury, Prevention and Management: How to Perform Cystoscopy and Place Ureteral Catheter. Invited. AAGL Advancing Minimally Invasive Gynecology Worldwide. New York, US.
2012. Risk Factors Associated with Conversion to Laparotomy in Patients Undergoing Robotic Surgery. Invited. AAGL Global Congress. Las Vegas, US.
2012. Gynecologic Oncology, Minimally Invasive and Robotic Surgery. Invited. 35th National Congress of the South African Society of Obstetricians & Gynecologists. Drakensberg, ZA.
2010. Minimally Invasive Surgery for Cervical and Endometrial Cancer. Invited. Congress on Minimally Invasive Surgery. Cordoba, AR.
2010. Minimally Invasive Oncology Surgery, Uterine and Cervical Cancer. Invited. The Obstetrics and Gynecology Society of Cordoba - VIII Congress of Gynecology and Obstetrics - 76th Anniversary Conference. Cordoba, AR.
2010. Minimally Invasive Oncology Surgery, Ovary Cancer. Invited. The Obstetrics and Gynecology Society of Cordoba-VIII Congress of Gynecology and Obstetrics - 76th Anniversary Conference. Cordoba, AR.
2010. Minimally Invasive Oncology Surgery Training and Accreditation. Invited. The Obstetrics and Gynecology Society of Cordoba - VIII Congress of Gynecology and Obstetrics- 76th Anniversary Conference. Cordoba, AR.
2010. Minimally Invasive Surgery for Ovarian Cancer. Invited. Congress on Minimally Invasive Surgery. Cordoba, AR.
2010. Minimally Invasive Surgery in Gynecologic Oncology. Invited. Minimally Invasive Surgery Symposium. Delhi, IN.
2010. Minimal Access Surgery in Gynecological Oncology: Whence We Came-Whither We Go. Invited. Hinduja Hospital Gynacological Oncology Practicum. Mumbai, IN.
2010. Is there a hereditary component in uterine cancer? Risk factors and screening. Invited. 2nd Annual MD Anderson Madrid Symposium in Gynecologic Oncology. Madrid, ES.
2009. Minimally Invasive Surgery for Cervical Cancer. Invited. Hospital Oncologico "Julio Villacreses Colmont". Manabi, EC.
2009. Minimally Invasive Surgery for Early Cervical Cancer. Invited. Argentinean Association of Gynecologic Oncology/Felix Rutledge Society Annual Meeting. Buenos Aires, AR.

Formal Peers

2019. Grand Rounds Lecture: Sentinel Lymph Node Mapping in Cervix and Endometrial Cancer. Invited. Atlanta, GA, US.
2013. Fertility Preservation in the Cancer Survivor. Invited. Houston, TX, US.
2013. Ovarian Conservation. Invited. Houston, TX, US.
2011. Healthy Women's Seminar. Invited. Cleveland, TX, US.
2005. Women with synchronous primary cancers of the endometrium and ovary: Do they have Lynch Syndrome (HNPCC)?. Invited. London, GB.

Less

Grant & Contract Support

Date:	2019 - 2021
Title:	Molecular Classification of Uterine Serous Cancer, the MUSC Study
Funding Source:	MD Anderson Cancer Center Sister Institute Network Fund
Role:	PI

Date:	2019 - 2026
Title:	A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of INCMGA00012 in Patients with Advanced Solid Tumors
Funding Source:	Incyte Corporation
Role:	PI

Date:	2017
Title:	A Phase II, Single‐Arm Study of Ribociclib (LEE011), Everolimus, and Letrozole, in Patients with Advanced or Recurrent Endometrial Carcinoma
Funding Source:	NOVARTIS
Role:	PI
ID:	2015-0961

Date:	2014 - 2021
Title:	MD Anderson Gynecologic SPORE for Endometrial Cancer
Funding Source:	NIH/NCI
Role:	Co-I
ID:	5P50CA098258-09

Date:	2014 - 2015
Title:	A Phase II, Single-Arm Study RAD001 (Everolimus, Letrozole, and Metformin in Patients with Advanced or Recurrent Endometrial Carcinoma
Funding Source:	UTMDACC (HI-CRSP)
Role:	PI
ID:	2012-0543

Date:	2013 - 2019
Title:	Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients with Advanced or Recurrent Endometrial Carcinoma, Phase II
Funding Source:	Novartis/SPORE
Role:	PI

Date:	2012 - Present
Title:	A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients with Advanced or Recurrent Endometrial Carcinoma
Funding Source:	Novartis Pharmaceutical Corporation
Role:	PI

Date:	2012 - 2014
Title:	Sister Institute Network Fund-A Pilot Study of Acupuncture for the Treatment of Chronic, Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors
Funding Source:	UT MDACC Sister Institution Network Fund (SINF)
Role:	Collaborator

Date:	2011 - 2014
Title:	A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole and Metformin in Patients with Advanced or Recurrent Endometrial Carcinoma "Letrozole Metformin"
Funding Source:	Novartis
Role:	PI
ID:	CRAD001CUS295T

Date:	2010 - 2013
Title:	A Phase II Study of Postoperative Intensity Modulated Radiation Therapy (IMRT)
Funding Source:	Radiation Therapy Oncology Group
Role:	Co-I
ID:	RTOG0921

Date:	2010 - 2015
Title:	Project 2: Strategy for the Incorporation of Tissue Biomarkers in the Clinical Management of Endometrial Cancer Patients
Funding Source:	NIH/NCI
Role:	Co-I
ID:	2 P50 CA098258 06 A2 (PP-2)

Date:	2010 - 2011
Title:	MD Anderson Gynecologic SPORE for Endometrial Cancer Career Development Award- The prevalence of Endometrial Abnormalities in Obese Women: An Evaluation of Molecular Markers
Funding Source:	NIH/NCI
Role:	PI
ID:	5 P50 CA098258

Date:	2010 - 2011
Title:	"New use for an old drug: evaluation of the molecular effects of Metformin on the endometrium of women with newly diagnosed endometrial cancer"
Funding Source:	American Cancer Society (ACS)
Role:	PI

Date:	2010 - 2012
Title:	New use for an old drug " Evaluation of the molecular effects of Metformin on the endometrium of women with newly diagnosed endometrial cancer"
Funding Source:	Executive Committee of the Texas Business Women
Role:	PI

Title:	Can Exercise Prevent Ovarian Cancer Recurrence: Mechanisms and Biomarkers
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	RFA-PAR-12-228

Title:	Phase II, Single-arm study, everolimus, utrolzole + ribociclib
Funding Source:	Novartis
Role:	PI

Selected Publications

Peer-Reviewed Articles

Knisely, A, Dai, Y, Barlow, GL, Lee, S, Lawson, BC, Clark, HD, Fellman, B, Yuan, Y, Lu, W, Lubo Julio, IC, Lazcano, RN, Chelvanambi, M, Melendez, B, Singh, BB, Singh, B, Wani, K, Chen, J, Yeh, CC, Gao, J, Barnes, S, Shi, O, Khan, KB, Serrano, A, Gomez Bolanos, L, Scalise, CB, Cheung, SK, Dutta, P, Velichko, S, ElNaggar, AC, Liu, MC, Wilke, RN, How, JA, Ramondetta, LM, Boruta II, DM, Richardson, G, Shafer, A, Westin, SN, Sims, TT, Sood, AK, Ramirez, PT, Lazar, A, Soliman, PT, Lu, KH, Haymaker, CL, Solis Soto, LM, Wargo, J, Grisham, RN, Wucherpfennig, K, Wang, L, Jazaeri, AA. Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy. Clinical Cancer Research 31(19):4122-4135, 2025. e-Pub 2025. PMID: 40748258.
Dai, Y, Knisely, A, Yano, M, Dang, M, Hinchcliff, EM, Lee, S, Welp, A, Chelvanambi, M, Lastrapes, M, Liu, H, Yuan, Z, Wang, C, Nie, H, Jean, S, Montaner, LJ, Hou, J, Patel, A, Patel, S, Fellman, B, Yuan, Y, Sun, B, Pandurengan, RK, Cuentas, EP, Celestino, J, Liu, Y, Liu, J, Hillman, RT, Westin, SN, Sood, AK, Soliman, PT, Shafer, A, Meyer, LA, Gershenson, DM, Vining, D, Ganeshan, DM, Lu, KH, Wargo, J, Peng, W, Zhang, R, Wang, L, Jazaeri, AA. PPP2R1A mutations portend improved survival after cancer immunotherapy. Nature 644(8076):537-546, 2025. e-Pub 2025. PMID: 40604275.
Abu-Rustum, NR, Campos, SM, Amarnath, SR, Arend, RC, Barber, EL, Bradley, KA, Brooks, R, Chino, JP, Chon, HS, Crispens, MA, Damast, S, Fisher, C, Frederick, PJ, Gaffney, DK, Gaillard, S, Giuntoli, RL, Glaser, S, Howitt, BE, Landrum, LM, Lea, JS, Lee, N, Mantia-Smaldone, G, Mariani, A, Mutch, DG, Nagel, C, Nekhlyudov, L, Nieto, K, Nwachukwu, C, Podoll, M, Rodabaugh, KJ, Salani, R, Schorge, JO, Schuetze, S, Siedel, J, Sisodia, R, Soliman, PT, Ueda, S, Urban, R, Wyse, E, McMillian, NR, Sambandam, V. Uterine Neoplasms, Version 3.2025 Featured Updates to the NCCN Guidelines®. JNCCN Journal of the National Comprehensive Cancer Network 23(8):284-291, 2025. e-Pub 2025. PMID: 40763788.
Asare, A, Previs, RA, Spinosa, D, Fellman, B, Scott, AL, Mulder, I, Mahmoud, M, Enbaya, A, Siedel, J, Cobb, LP, Soliman, PT, Sood, AK, Coleman, R, Secord, AA, Westin, SN. Bevacizumab beyond progression. Gynecologic oncology 194:112-118, 2025. e-Pub 2025. PMID: 39987772.
Guo, F, Adekanmbi, V, Hsu, CD, Hoang, T, Soliman, PT, Baillargeon, J, Berenson, AB. Trends in Endometrial Cancer Incidence Among Premenopausal and Postmenopausal Women in the United States Between 2001 and 2021. Cancers 17(6), 2025. e-Pub 2025. PMID: 40149367.
Piha-Paul, SA, Tseng, C, Tran, HT, Naing, A, Dumbrava, EE, Karp, DD, Rodon Ahnert, J, Yap, TA, Raghav, KS, Damodaran, S, Le, X, Soliman, PT, Lim, J, Meric-Bernstam, F. Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with ErbB family gene alterations. ESMO Open 10(2), 2025. e-Pub 2025. PMID: 39908697.
Ahmed, J, Stephen, B, Khawaja, MR, Yang, Y, Salih, I, Barrientos Toro, E, Raso, G, Karp, DD, Piha-Paul, SA, Sood, AK, Ng, CS, Johnson, A, Soliman, PT, Meric-Bernstam, F, Lu, KH, Naing, A. A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer. Gynecologic oncology 193:73-80, 2025. e-Pub 2025. PMID: 39787747.
Saab, R, Fellman, B, Legarreta, AF, Meyer, LA, Fleming, N, Ratan, R, Nassif, EF, Frumovitz, M, Soliman, PT. Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma. Gynecologic oncology 191:143-149, 2024. e-Pub 2024. PMID: 39396406.
Rios-Doria, E, Abu-Rustum, NR, Glaser, G, McGree, M, Eriksson, AZ, Pham, MM, Soliman, PT, Ataseven, B, Alektiar, KM, Zamarin, D, Leitao, M, Mueller, JJ. 2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer. International Journal of Gynecological Cancer 34(10):1580-1587, 2024. e-Pub 2024. PMID: 39074930.
Cun, HT, Bernard, L, Lande, KT, Lawson, BC, Nesbakken, AJ, Davidson, B, Lindemann, K, Fellman, B, Sørlie, T, Soliman, PT, Eriksson, AZ. Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma. Gynecologic oncology 189:138-145, 2024. e-Pub 2024. PMID: 39126895.
Huepenbecker, S, Soliman, PT, Meyer, LA, Iniesta-Donate, M, Chisholm, GB, Taylor, JS, Wilke, RN, Fleming, N. Perioperative outcomes in gynecologic pelvic exenteration before and after implementation of an enhanced recovery after surgery program. Gynecologic oncology 189:80-87, 2024. e-Pub 2024. PMID: 39042957.
Son, J, Zhang, Y, Lin, Y, Mirallas, O, Ballesteros, PA, Nardo, M, Clark, N, Hillman, RT, Campbell, E, Holla, V, Johnson, A, Biter, A, Yuan, Y, Cobb, LP, Gershenson, DM, Jazaeri, AA, Lu, KH, Soliman, PT, Westin, SN, Euscher, ED, Lawson, BC, Yang, RK, Meric-Bernstam, F, Hong, DS. Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers. Clinical Cancer Research 30(14):2986-2995, 2024. e-Pub 2024. PMID: 38687597.
Nakazawa, MS, Silverman, IM, Rimkunas, V, Veloso, A, Glodzik, D, Johnson, A, Ohsumi, TK, Patel, S, Conley, AP, Roland, CL, Soliman, PT, Beird, H, Wu, C, Ingram, D, Segura Lazcano, R, Song, D, Wani, K, Lazar, A, Yap, TA, Wang, W, Andrew Livingston, J. Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Molecular cancer therapeutics 23(7):1057-1065, 2024. e-Pub 2024. PMID: 38561019.
Hinchcliff EM, Knisely A, Adjei N, Fellman B, Yuan Y, Patel A, Xu C, Westin SN, Sood AK, Soliman PT, Shafer A, Fleming ND, Gershenson DM, Vikram R, Bathala T, Vining D, Ganeshan DM, Lu KH, Sun CC, Meyer LA, Jazaeri AA. Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer 130(7):1061-1071, 2024. e-Pub 2023. PMID: 38009662.
Knisely, A, Iniesta, MD, Batman, S, Meyer, LA, Soliman, PT, Cain, K, Marten, CA, Chisholm, G, Schmeler, KM, Taylor, JS, Fleming, N. Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center. Gynecologic oncology 183:120-125, 2024. e-Pub 2024. PMID: 38368180.
Liu, W, Meyer, LA, Morse, M, Li, Y, Song, J, Engle, R, Lopez, G, Narayanan, S, Soliman, PT, Ramondetta, LM, Bruera, E, Cohen, L. Dietary Magnesium Replacement for Prevention of Hypomagnesemia in Patients with Ovarian Cancer Receiving Carboplatin-Based Chemotherapy. JCO Oncology Practice 20(4):517-524, 2024. e-Pub 2024. PMID: 38301188.
Abu-Rustum, NR, Yashar, CM, Arend, RC, Barber, EL, Bradley, KA, Brooks, R, Campos, SM, Chino, JP, Chon, HS, Crispens, MA, Damast, S, Fisher, C, Frederick, PJ, Gaffney, D, Gaillard, S, Giuntoli, RL, Glaser, S, Holmes, JA, Howitt, BE, Kendra, KL, Lea, JS, Lee, N, Mantia-Smaldone, G, Mariani, A, Mutch, DG, Nagel, C, Nekhlyudov, L, Podoll, M, Rodabaugh, KJ, Salani, R, Schorge, JO, Siedel, J, Sisodia, R, Soliman, PT, Ueda, S, Urban, R, Wethington, SL, Wyse, E, Zanotti, K, McMillian, NR, Espinosa, S. Vulvar Cancer, Version 3.2024. JNCCN Journal of the National Comprehensive Cancer Network 22(2):117-135, 2024. e-Pub 2024. PMID: 38503056.
Yoder AK, Lakomy DS, Wu J, Andring LM, Corrigan KL, Fellman B, Jhingran A, Klopp AH, Colbert LE, Soliman PT, Frumovitz MM, Peterson SK, Lin LL. Comparing long-term sexual dysfunction across different uterine cancer treatment modalities. Brachytherapy 23(1):1-9, 2024. e-Pub 2023. PMID: 37914588.
Rios-Doria E, Cun HT, Filippova OT, Mueller JJ, Alektiar KM, Ellenson LH, Makker V, Lakhman Y, Leitao MM, Jhingran A, Soliman PT, Abu-Rustum NR. Isolated vaginal recurrence in women with stage I endometrial cancer. Gynecol Oncol 179:9-15, 2023. e-Pub 2023. PMID: 37864854.
Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Holmes J, Howitt BE, Lea J, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian NR, Aggarwal S, Espinosa S. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. J Natl Compr Canc Netw 21(12):1224-1233, 2023. e-Pub 2023. PMID: 38081139.
Patel C, Bruno M, Rukundo I, Dains J, Martinez A, Soliman P. A new leadership frontier: Nurse practitioners and physician associates as inpatient medical directors. J Am Assoc Nurse Pract 35(8):457-460, 2023. e-Pub 2023. PMID: 37249389.
Zhukovsky DS, Soliman P, Liu D, Meyer M, Haider A, Heung Y, Gaeta S, Lu K, Stepan K, Stanton P, Rodriguez A, Bruera E. Patient Engagement With Early Stage Advance Care Planning at a Comprehensive Cancer Center. Oncologist 28(6):542-550, 2023. e-Pub 2023. PMID: 36848260.
Abu-Rustum, NR, Yashar, CM, Arend, RC, Barber, EL, Bradley, KA, Brooks, R, Campos, SM, Chino, JP, Chon, HS, Chu, C, Crispens, MA, Damast, S, Fisher, C, Frederick, PJ, Gaffney, D, Giuntoli, RL, Han, E, Holmes, JA, Howitt, BE, Lea, JS, Mariani, A, Mutch, DG, Nagel, C, Nekhlyudov, L, Podoll, M, Salani, R, Schorge, JO, Siedel, J, Sisodia, R, Soliman, PT, Ueda, S, Urban, R, Wethington, SL, Wyse, E, Zanotti, K, McMillian, NR, Aggarwal, S. Uterine Neoplasms, Version 1.2023. JNCCN Journal of the National Comprehensive Cancer Network 21(2):181-209, 2023. e-Pub 2023. PMID: 36791750.
Yoder, AK, Lakomy, DS, Wu, J, Andring, L, Fellman, B, Colbert, LE, Jhingran, A, Klopp, AH, Soliman, PT, Peterson, SK, Lin, LL. Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors. Clinical Oncology 35(2):e215-e226, 2023. e-Pub 2023. PMID: 36494250.
Hinchcliff E, Rumpf J, Ratan R, Fleming ND, Jazaeri A, Fellman B, Meyer L, Soliman P. Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma. Gynecol Oncol 167(3):490-495, 2022. e-Pub 2022. PMID: 36270831.
Kurnit KC, Nobre SP, Fellman BM, Iglesias DA, Lindemann K, Jhingran A, Eriksson AGZ, Ataseven B, Glaser GE, Mueller JJ, Westin SN, Soliman PT. Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study. Gynecol Oncol 167(3):452-457, 2022. e-Pub 2022. PMID: 36243601.
Handley KF, Sood AK, Molin GZD, Westin SN, Meyer LA, Fellman B, Soliman PT, Coleman RL, Fleming ND. Frailty repels the knife: The impact of frailty index on surgical intervention and outcomes. Gynecol Oncol 166(1):50-56, 2022. e-Pub 2022. PMID: 35599168.
Lakomy, DS, Yoder, AK, Wu, J, Hernandez, M, Ayoola-Adeola, M, Jhingran, A, Klopp, AH, Soliman, PT, Peterson, SK, Lin, LL. Impact of treatment modality on pelvic floor dysfunction among uterine cancer survivors. International Journal of Gynecological Cancer 32(10):1266-1275, 2022. e-Pub 2022. PMID: 35680139.
Westin SN, Labrie M, Litton JK, Blucher A, Fang Y, Vellano CP, Marszalek JR, Feng N, Ma X, Creason A, Fellman B, Yuan Y, Lee S, Kim TB, Liu J, Chelariu-Raicu A, Chen TH, Kabil N, Soliman PT, Frumovitz M, Schmeler KM, Jazaeri A, Lu KH, Murthy R, Meyer LA, Sun CC, Sood AK, Coleman RL, Mills GB. Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clin Cancer Res 27(23):6354-6365, 2021. e-Pub 2021. PMID: 34518313.
Fleming ND, Westin SN, Rauh-Hain JA, Soliman PT, Fellman BM, Coleman RL, Meyer LA, Shafer A, Cobb LP, Jazaeri A, Lu KH, Sood AK. Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer. Gynecol Oncol 162(1):65-71, 2021. e-Pub 2021. PMID: 33838925.
How JA, Patel S, Fellman B, Lu KH, Hwu P, Ramondetta LM, Westin SN, Fleming ND, Soliman PT, Jazaeri AA. Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer. Gynecol Oncol 162(1):24-31, 2021. e-Pub 2021. PMID: 33958211.
Zhukovsky DS, Haider A, Williams JL, Naqvi S, Joshi N, Mills S, Soliman PT, Mathew B, Bodurka D, Meyer LA, Westin S, Frumovitz M, Nowitz MB, Archie L, Fenton S, Lang K, Boving V, Bruera E. An Integrated Approach to Selecting a Prepared Medical Decision-Maker. J Pain Symptom Manage 61(6):1305-1310, 2021. e-Pub 2021. PMID: 33348030.
Coleman RL, Hu W, Soliman P, Nick A, Ramirez PT, Westin SN, Garcia ME, Zhu Z, Palancia J, Fellman BM, Yuan Y, Ram P, Bischoff F, Schmeler K, Bodurka D, Meyer LA, Sood AK. Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study. Gynecol Oncol 161(1):104-112, 2021. e-Pub 2021. PMID: 33551196.
How JA, Jazaeri AA, Soliman PT, Fleming ND, Gong J, Piha-Paul SA, Janku F, Stephen B, Naing A. Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial. Sci Rep 11(1):3667, 2021. e-Pub 2021. PMID: 33574401.
Fleming ND, Westin SN, Meyer LA, Shafer A, Rauh-Hain JA, Onstad M, Cobb L, Bevers M, Fellman BM, Burzawa J, Bhosale P, Zand B, Jazaeri A, Levenback C, Coleman RL, Soliman PT, Sood AK. Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer. Int J Gynecol Cancer 31(1):92-97, 2021. e-Pub 2021. PMID: 33154095.
Bailey CD, Previs R, Fellman BM, Zaid T, Huang M, Brown A, Enbaya A, Balakrishnan N, Broaddus RR, Bodurka DC, Soliman P, Fleming ND, Nick A, Sood AK, Westin SN. Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer. Int J Gynecol Cancer. e-Pub 2020. PMID: 33122243.
Grassi T, Mariani A, Cibula D, Soliman PT, Suman VJ, Weaver AL, Pedra Nobre S, Weigelt B, Glaser GE, Cappuccio S, Abu-Rustum NR. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial). Int J Gynecol Cancer 30(10):1627-1632, 2020. e-Pub 2020. PMID: 32699021.
Hu W, Zhang L, Ferri-Borgogno S, Kwan SY, Lewis KE, Cun HT, Yeung TL, Soliman PT, Tarapore RS, Allen JE, Guan X, Lu KH, Mok SC, Au-Yeung CL. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers (Basel) 12(9), 2020. e-Pub 2020. PMID: 32867127.
Dottino JA, Zhang Q, Loose DS, Fellman B, Melendez BD, Waters MS, McKenzie LJ, Yuan Y, Yang RK, Broaddus RR, Lu KH, Soliman PT, Yates MS. Endometrial biomarkers in premenopausal obese women: an at-risk cohort. Am J Obstet Gynecol. e-Pub 2020. PMID: 32835719.
Westin SN, Fellman B, Sun CC, Broaddus RR, Woodall ML, Pal N, Urbauer DL, Ramondetta LM, Schmeler KM, Soliman PT, Fleming ND, Burzawa JK, Nick AM, Milbourne AM, Yuan Y, Lu KH, Bodurka DC, Coleman RL, Yates MS. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer. Am J Obstet Gynecol. e-Pub 2020. PMID: 32805208.
Onstad M, Ducie J, Fellman BM, Abu-Rustum NR, Leitao M, Mariani A, Multinu F, Lu KH, Soliman P. Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus. Int J Gynecol Cancer 30(4):485-490, 2020. e-Pub 2020. PMID: 31980487.
Stewart KI, Eska JS, Harrison RF, Suidan R, Abraham A, Chisholm GB, Meyer LA, Westin SN, Fleming ND, Frumovitz M, Aloia TA, Soliman PT. Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges. Int J Gynecol Cancer 30(3):352-357, 2020. e-Pub 2020. PMID: 31911539.
Soliman PT, Westin SN, Iglesias DA, Fellman BM, Yuan Y, Zhang Q, Yates MS, Broaddus RR, Slomovitz BM, Lu KH, Coleman RL. Everolimus, letrozole, and metformin in women with advanced or recurrent endometrioid endometrial cancer: A multi-center, single arm, phase II study. Clin Cancer Res 26(3):581-587, 2020. e-Pub 2020. PMID: 31628143.
Zhukovsky DS, Soliman PT, Mathew B, Mills S, Bodurka D, Frumovitz M, Meyer LA, Westin S, Nowitz M, Archie L, Fenton S, Lang K, Williams JL, Boving V, Bruera E. Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center. J Oncol Pract 15(12):JOP1900109, 2019. e-Pub 2019. PMID: 31613720.
Sam A, George J, Taylor J, Hwang J, Chisholm G, Granwehr B, Soliman P, Schmeler K. Improving the Prevalence of HIV Testing Among Patients in a Gynecologic Oncology Department: Results of a Quality Improvement Project. J Oncol Pract:JOP1900382. e-Pub 2019. PMID: 31730416.
Stewart KI, Chasen B, Erwin W, Fleming N, Westin SN, Dioun S, Frumovitz M, Ramirez PT, Lu KH, Wong F, Aloia TA, Soliman PT. Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study. Cancer 125(19):3347-3353, 2019. e-Pub 2019. PMID: 31225906.
Matsuo K, Cripe JC, Kurnit KC, Kaneda M, Garneau AS, Glaser GE, Nizam A, Schillinger RM, Kuznicki ML, Yabuno A, Yanai S, Garofalo DM, Suzuki J, St Laurent JD, Yen TT, Liu AY, Shida M, Kakuda M, Oishi T, Nishio S, Marcus JZ, Adachi S, Kurokawa T, Ross MS, Horowitz MP, Johnson MS, Kim MK, Melamed A, Machado KK, Yoshihara K, Yoshida Y, Enomoto T, Ushijima K, Satoh S, Ueda Y, Mikami M, Rimel BJ, Stone RL, Growdon WB, Okamoto A, Guntupalli SR, Hasegawa K, Shahzad MMK, Im DD, Frimer M, Gostout BS, Ueland FR, Nagao S, Soliman PT, Thaker PH, Wright JD, Roman LD. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer. Gynecol Oncol 155(1):39-50, 2019. e-Pub 2019. PMID: 31427143.
Armbruster SD, Previs R, Soliman PT, Westin SN, Fellman B, Jhingran A, Fleming ND. Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience. Gynecol Oncol 154(2):328-332, 2019. e-Pub 2019. PMID: 31221496.
Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. Gynecol Oncol 154(1):22-28, 2019. e-Pub 2019. PMID: 31109659.
Liu W, Qdaisat A, Soliman PT, Ramondetta L, Lopez G, Narayanan S, Zhou S, Cohen L, Bruera E, Yeung SJ. Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin. Oncologist 24(6):e312-e317, 2019. e-Pub 2019. PMID: 30940743.
Casarin J, Multinu F, Abu-Rustum N, Cibula D, Cliby WA, Ghezzi F, Leitao M, Konishi I, Nam JH, Querleu D, Soliman PT, Yost KJ, Weaver AL, Mariani A, Glaser GE. Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists. Int J Gynecol Cancer 29(1):60-67, 2019. e-Pub 2019. PMID: 30640685.
Kurnit KC, Previs RA, Soliman PT, Westin SN, Klopp AH, Fellman BM, Lu KH, Ramondetta LM, Fleming ND. Prognostic factors impacting survival in early stage uterine carcinosarcoma. Gynecol Oncol 152(1):31-37, 2019. e-Pub 2019. PMID: 30414738.
Hansen JM, Sood AK, Coleman RL, Westin SN, Soliman PT, Ramirez PT, Fellman BM, Schmeler KM, Fleming ND. Concordance of a laparoscopic scoring algorithm with primary surgery findings in advanced stage ovarian cancer. Gynecol Oncol. e-Pub 2018. PMID: 30366647.
Ahmed M, Al-Khafaji JF, Class CA, Wei W, Ramalingam P, Wakkaa H, Soliman PT, Frumovitz M, Iyer RB, Bhosale PR. Can MRI help assess aggressiveness of endometrial cancer?. Clin Radiol 73(9):833.e11-833.e18, 2018. e-Pub 2018. PMID: 29895385.
Fleming ND, Nick AM, Coleman RL, Westin SN, Ramirez PT, Soliman PT, Fellman B, Meyer LA, Schmeler KM, Lu KH, Sood AK. Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer. Obstet Gynecol 132(3):545-554, 2018. e-Pub 2018. PMID: 30095787.
Jalloul RJ, Nick AM, Munsell MF, Westin SN, Ramirez PT, Frumovitz M, Soliman PT. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer. J Gynecol Oncol 29(5):e68, 2018. e-Pub 2018. PMID: 30022632.
Nishio S, Matsuo K, Yonemoto K, Shimokawa M, Hosaka M, Kodama M, Miyake TM, Ushijima K, Kamura T, Westin SN, Soliman PT, Coleman RL. Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer. Oncotarget 9(64):32321-32330, 2018. e-Pub 2018. PMID: 30190789.
Suidan RS, Sun CC, Cantor SB, Mariani A, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LA. Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis. Obstet Gynecol 132(1):52-58, 2018. e-Pub 2018. PMID: 29889752.
Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PT. Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration. Gynecol Oncol 149(3):484-490, 2018. e-Pub 2018. PMID: 29622276.
Euscher E, Sui D, Soliman P, Westin S, Ramalingam P, Bassett R, Malpica A. Ultrastaging of Sentinel Lymph Nodes in Endometrial Carcinoma According to Use of 2 Different Methods. Int J Gynecol Pathol 37(3):242-251, 2018. e-Pub 2018. PMID: 28700425.
Bergstrom J, Aloisi A, Armbruster S, Yen TT, Casarin J, Leitao MM, Tanner EJ, Matsuno R, Machado KK, Dowdy SC, SSoliman PT, Wethington SL, Stone RL, Levinson KL, Fader AN. Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers. Gynecol Oncol 148(3):480-484, 2018. e-Pub 2018. PMID: 29338923.
Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu KH, Ramirez PT, Ramondetta L, Bodurka DC, Westin SN. Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device. Obstet Gynecol 131(1):109-116, 2018. e-Pub 2018. PMID: 29215513.
Roszik J, Ring KL, Wani KM, Lazar AJ, Yemelyanova AV, Soliman PT, Frumovitz M, Jazaeri AA. Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy. Front Immunol 9:2102, 2018. e-Pub 2018. PMID: 30283446.
Dioun SM, Fleming ND, Munsell MF, Lee J, Ramirez PT, Soliman PT. Setting Benchmarks for the New User: Training on the Robotic Simulator. JSLS 21(4), 2017. e-Pub 2017. PMID: 29279661.
Matsuo K, Machida H, Stone RL, Soliman PT, Thaker PH, Roman LD, Wright JD. Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer. Obstet Gynecol 130(2):403-410, 2017. e-Pub 2017. PMID: 28697110.
Soliman PT, Westin SN, Dioun S, Sun CC, Euscher E, Munsell MF, Fleming ND, Levenback C, Frumovitz M, Ramirez PT, Lu KH. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Gynecol Oncol. e-Pub 2017. PMID: 28528918.
Soliman PT. Should we perform routine peritoneal and staging biopsies at the time of risk-reducing bilateral salpingo-ophrectomy?. J Minim Invasive Gynecol. e-Pub 2017. PMID: 28536074.
Bhosale P, Ramalingam P, Ma J, Iyer R, Soliman P, Frumovitz M, Kundra V. Can reduced field-of-view diffusion sequence help assess microsatellite instability in FIGO stage 1 endometrial cancer?. J Magn Reson Imaging 45(4):1216-1224, 2017. e-Pub 2017. PMID: 27532860.
Holman LL, Pal N, Iglesias DA, Soliman PT, Balakrishnan N, Klopp A, Broaddus RR, Fleming ND, Munsell MF, Lu KH, Westin SN. Factors prognostic of survival in advanced-stage uterine serous carcinoma. Gynecol Oncol. e-Pub 2017. PMID: 28465008.
Suidan RS, He W, Sun CC, Zhao H, Fleming ND, Ramirez PT, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LA. Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. Gynecol Oncol 145(1):55-60, 2017. e-Pub 2017. PMID: 28131529.
Salvo G, Ramirez PT, Levenback CF, Munsell MF, Euscher ED, Soliman PT, Frumovitz M. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol 145(1):96-101, 2017. e-Pub 2017. PMID: 28188015.
Fleming ND, Ramirez PT, Soliman PT, Schmeler KM, Chisholm GB, Nick AM, Westin SN, Frumovitz M. Quality of life after radical trachelectomy for early-stage cervical cancer: A 5-year prospective evaluation. Gynecol Oncol 143(3):596-603, 2016. e-Pub 2016. PMID: 27742473.
Soliman PT, Zhang Q, Broaddus RR, Westin SN, Iglesias D, Munsell MF, Schmandt R, Yates M, Ramondetta L, Lu KH. Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study. Gynecol Oncol 143(3):466-471, 2016. e-Pub 2016. PMID: 27745917.
Brown AJ, Shah JS, Fleming ND, Nick AM, Soliman PT, Chisholm GB, Schmeler KM, Ramirez PT, Frumovitz M. Role of cervical cytology in surveillance after radical trachelectomy for cervical cancer. Gynecol Oncol 142(2):283-5, 2016. e-Pub 2016. PMID: 27246304.
Pakish JB, Lu KH, Sun CC, Burzawa JK, Greisinger A, Smith FA, Fellman B, Urbauer DL, Soliman PT. Endometrial Cancer Associated Symptoms: A Case-Control Study. J Womens Health (Larchmt). e-Pub 2016. PMID: 27254529.
Bhosale P, Ma J, Iyer R, Ramalingam P, Wei W, Soliman P, Frumovitz M, Kundra V. Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging 43(2):316-24, 2016. e-Pub 2016. PMID: 26185031.
Prescott LS, Dickens AS, Guerra SL, Tanha JM, Phillips DG, Patel KT, Umberson KM, Lozano MA, Lowe KB, Brown AJ, Taylor JS, Soliman PT, Garcia EA, Levenback CF, Bodurka DC. Fighting cancer together: Development and implementation of shared medical appointments to standardize and improve chemotherapy education. Gynecol Oncol 140(1):114-9, 2016. e-Pub 2016. PMID: 26549108.
McCampbell AS, Mittelstadt ML, Dere R, Kim S, Zhou L, Djordjevic B, Soliman PT, Zhang Q, Wei C, Hursting SD, Lu KH, Broaddus RR, Walker CL. Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity. Curr Mol Med 16(3):252-65, 2016. e-Pub 2016. PMID: 26917264.
Fleming ND, Soliman PT, Westin SN, dos Reis R, Munsell M, Klopp AH, Frumovitz M, Nick AM, Schmeler K, Ramirez PT. Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer. Int J Gynecol Cancer 25(8):1437-44, 2015. e-Pub 2015. PMID: 26332387.
Arms RG, Sun CC, Burzawa JK, Fleming ND, Nick AM, Rallapalli V, Westin SN, Meyer LA, Ramirez PT, Soliman PT. Improvement in quality of life after robotic surgery results in patient satisfaction. Gynecol Oncol 138(3):727-30, 2015. e-Pub 2015. PMID: 26197762.
Winkler SS, Malpica A, Soliman PT. Novel treatment of a central type, primitive neuroectodermal tumor of the ovary with postoperative pediatric medulloblastoma chemotherapy regimen: A case report and review of the literature. Gynecol Oncol Rep 13:57-9, 2015. e-Pub 2015. PMID: 26425724.
Grant JD, Garg AK, Gopal R, Soliman PT, Jhingran A, Eifel PJ, Klopp AH. Isolated port-site metastases after minimally invasive hysterectomy for endometrial cancer: outcomes of patients treated with radiotherapy. Int J Gynecol Cancer 25(5):869-74, 2015. e-Pub 2015. PMID: 25790043.
Dioun SM, Soliman PT. Laparoscopic hysterectomy with morcellation for a suspected uterine fibroid resulting in dissemination of cervical adenocarcinoma: A case report. Gynecol Oncol Rep 12:5-6, 2015. e-Pub 2015. PMID: 26076147.
Slomovitz BM, Jiang Y, Yates MS, Soliman PT, Johnston T, Nowakowski M, Levenback C, Zhang Q, Ring K, Munsell MF, Gershenson DM, Lu KH, Coleman RL. Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma. J Clin Oncol 33(8):930-6, 2015. e-Pub 2015. PMID: 25624430.
Dioun SM, Soliman PT. Laparoscopic hysterectomy with morcellation for a suspected uterine fibroid resulting in dissemination of cervical adenocarcinoma: A case report. Gynecol Oncol Reports:5-6, 2015. e-Pub 2015.
Fleming ND, Frumovitz M, Schmeler KM, Dos Reis R, Munsell MF, Eifel PJ, Soliman PT, Nick AM, Westin SN, Ramirez PT. Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. Gynecol Oncol 136(1):48-53, 2015. e-Pub 2015. PMID: 25451695.
Slomovitz BM, Jiang Y, Yates MS, Soliman PT, Johnston T, Nowakowski M, Levenback C, Zhang Q. Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma. J Clin Oncol. e-Pub 2015. PMID: 256254430.
Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler KM, Eifel PJ. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol 145(6):1098-104, 2014. e-Pub 2014. PMID: 25415160.
Costales AB, Schmeler KM, Broaddus R, Soliman PT, Westin SN, Ramirez PT, Frumovitz M. Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia. Gynecol Oncol 135(3):451-4, 2014. e-Pub 2014. PMID: 25316176.
Carroll A, Ramirez PT, Westin SN, Soliman PT, Munsell MF, Nick AM, Schmeler KM, Klopp AH, Fleming ND. Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence. Gynecol Oncol 135(3):455-61, 2014. e-Pub 2014. PMID: 25449308.
Ulm MA, Fleming ND, Rallapali V, Munsell MF, Ramirez PT, Westin SN, Nick AM, Schmeler KM, Soliman PT. Position-related injury is uncommon in robotic gynecologic surgery. Gynecol Oncol 135(3):534-8, 2014. e-Pub 2014. PMID: 25449565.
Torres D, Myers JA, Eshraghi LW, Riley EC, Soliman PT, Milam MR. Risk Factors for the Development of Uterine Cancer in Breast Cancer Survivors: An Army of Women Study. Ann Surg Oncol. e-Pub 2014. PMID: 25361886.
Lyons YA, Frumovitz M, Soliman PT. Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation. Gyn Oncol Reports(18 Sept 2014), 2014. e-Pub 2014.
Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol 134(3):546-51, 2014. e-Pub 2014. PMID: 25014540.
Jones N, Fleming ND, Nick AM, Munsell MF, Rallapalli V, Westin SN, Meyer LA, Schmeler KM, Ramirez PT, Soliman PT. Conversion from robotic surgery to laparotomy: A case-control study evaluating risk factors for conversion. Gynecol Oncol 134(2):238-42, 2014. e-Pub 2014. PMID: 24937481.
Slaughter KN, Frumovitz M, Schmeler KM, Nick AM, Fleming ND, Reis RD, Munsell MF, Westin SN, Soliman PT, Ramirez PT. Minimally invasive surgery for endometrial cancer: Does operative start time impact surgical and oncologic outcomes?. Gynecol Oncol 134(2):248-52, 2014. e-Pub 2014. PMID: 24945591.
Patel PR, Nick AM, Frumovitz M, Militello A, Schmeler KM, Soliman PT, Dos Reis R, Ramirez PT. Intraoperative Complications During Gynecologic Laparoscopy. J Minim Invasive Surg Sci, 2014. e-Pub 2014.
Pakish J, Soliman PT, Frumovitz M, Westin SN, Schmeler KM, Reis RD, Munsell MF, Ramirez PT. A comparison of extraperitoneal versus transperitoneal laparoscopic or robotic para-aortic lymphadenectomy for staging of endometrial carcinoma. Gynecol Oncol 132(2):366-371, 2014. e-Pub 2014. PMID: 24361579.
Frumovitz M, Coleman RC, Soliman PT, Ramirez PT, Levenback CF. A case for caution in the pursuit of the sentinel node in women with endometrial carcinoma. Gynecol Oncol 132(2):275-279, 2014. e-Pub 2014. PMID: 24291694.
Huang M, Iglesias DA, Westin SN, Fellman B, Urbauer D, Schmeler KM, Frumovitz M, Ramirez PT, Soliman PT. Pelvic exenteration: impact of age on surgical and oncologic outcomes. Gynecol Oncol 132(1):114-118, 2014. e-Pub 2014. PMID: 24262877.
Bruegl AS, Djordjevic B, Urbauer DL, Westin SN, Soliman PT, Lu KH, Luthra R, Broaddus RR. Utility of MLH1 methylation analysis in the clinical evaluation of lynch syndrome in women with endometrial cancer. Curr Pharm Des 20(11):1655-1663, 2014. e-Pub 2014. PMID: 23888949.
Soliman PT, Iglesias D, Munsell MF, Frumovitz M, Westin SN, Nick AM, Schmeler KM, Ramirez PT. Successful incorporation of robotic surgery into gynecologic oncology fellowship training. Gynecol Oncol 131(3):730-733, 2013. e-Pub 2013. PMID: 24055616.
Clark LH, Soliman PT, Odetto D, Munsell MF, Schmeler KM, Fleming N, Westin SN, Nick AM, Ramirez PT. Incidence of trocar site herniation following robotic gynecologic surgery. Gynecol Oncol 131(2):400-403, 2013. e-Pub 2013. PMID: 23988416.
Urh A, Soliman PT, Schmeler KM, Westin S, Frumovitz M, Nick AM, Fellman B, Urbauer DL, Ramirez PT. Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies. Gynecol Oncol 129(3):580-5, 2013. e-Pub 2013. PMID: 23480870.
Soliman PT, Langley G, Munsell MF, Vaniya HA, Frumovitz M, Ramirez PT. Analgesic and antiemetic requirements after minimally invasive surgery for early cervical cancer: A comparison between laparoscopy and robotic surgery. Ann Surg Oncol 20(4):1355-9, 2013. e-Pub 2013. PMID: 23054117.
Schmeler KM, Langley G, Cain K, Munsell MF, Ramirez PT, Soliman PT, Nick AM, Frumovitz M, Coleman RL, Kroll MH, Levenback CF. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gyn Oncol 128(2):204-8, 2013. e-Pub 2013. PMID: 23200912.
Shirvani SM, Klopp AH, Likhacheva A, Jhingran A, Soliman PT, Lu KH, Eifel PJ. Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Pract Rad Oncol 3(1):e21-e28, 2013. e-Pub 2013.
Frumovitz M, Euscher E, Deavers M, Soliman PT, Schmeler K, Ramirez PT, Levenback C. "Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer. Gynec Oncol 127(3):467-71, 2012. e-Pub 2012. PMID: 22910691.
Zand B, Frumovitz M, Jofre MF, Nick AM, dos Reis R, Munsell MF, Sangi-Haghpeykar H, Levenback C, Soliman PT, Ramirez PT. Risk factors for prolonged hospitalization after gynecologic laparoscopic surgery. Gyn Oncol 126(3):428-31, 2012. e-Pub 2012. PMID: 22668880.
Graybill WS, Frumovitz MM, Nick AM, Wei C, Mena GE, Soliman PT, dos Reis R, Schmeler KM, Ramirez PT. Impact of smoking on perioperative pulmonary complications after laparoscopic gynecologic surgery. Gynec Oncol 125(3):556-60, 2012. e-Pub 2012. PMID: 22433464.
Pareja R, Nick AM, Schmeler KM, Frumovitz M, Soliman PT, Buitrago CA, Borrero M, Gonzalo A, dos Reis R, Ramirez PT. Quality of laparoscopic radical hysterectomy in developing countries: a comparison of surgical and oncologic outcomes between a comprehensive cancer center in the United States and a cancer center in Colombia. Gynec Oncol 125(2):326-9, 2012. e-Pub 2012.
Iglesias D, Westin S, Rallapalli V, Huang M, Fellman B, Urbauer D, Frumovitz M, Ramirez PT, Soliman PT. The effect of body mass index on surgical outcomes and survival following pelvic exenteration. Gynecol Oncol 125(2):336-42, 2012. e-Pub 2012.
Escobar PF, Frumovitz M, Soliman PT, Frasure HE, Fader AN, Schmeler KM, Ramirez PT. Comparison of Single-port laparoscopy, standard laparoscopy, and robotic surgery in patients with endometrial cancer. Ann Surg Oncol 19(5):1583-8, 2012. e-Pub 2012.
Worley Jr MJ, Anwandter C, Sun CC, dos Reis R, Nick AM, Frumovitz M, Coleman RK, Soliman PT, Schmeler KM, Levenback CF, Ramirez PT. Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery. Gyn Oncol 125(1):241-4, 2012. e-Pub 2012.
Berger JL, Westin SN, Fellman B, Rallapaili V, Frumovitz M, Ramirez PT, Sood AK, Soliman PT. Modified vertical rectus abdominis myocutaneous flap vaginal reconstruction: An analysis of surgical outcomes. Gynec Oncol 125(1):252-5, 2012. e-Pub 2012.
Covert WM, Westin S, Soliman PT, Langley GD. The role of muco-regulatory agents after continent urinary diversion?. Am J Health-Sys Pharm 15(6):483-6, 2012. e-Pub 2012.
Frumovitz M, Kriseman ML, Sun C, Blumenthal-Barby J, Sood AK, Bodurka DC, Soliman PT. Unverifiable accomplishments and publications on applications for gynecologic oncology fellowships. Obstet Gyn 119(3):504-8, 2012. e-Pub 2012.
Nick AM, Frumovitz M, Soliman PT, Schmeler KM, Ramirez PT. Fertility sparing surgery for treatment of early-stage cervical cancer: open vs. robotic radical trachelectomy. Gyn Oncology 124(2):276-80, 2012. e-Pub 2012. PMID: 22035808.
Ramirez PT, Adams S, Boggess JF, Burke WM, Frumovitz MM, Gardner GJ, Havrilesky LJ, Holloway R, Lowe MP, Magrina JF, Moore DH, Soliman PT, Yap S. Robotic-assisted surgery in gynecologic oncology: A Society of Gynecologic Oncology consensus statement developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. Gynecol Oncol 124(2):180-4, 2012. e-Pub 2012.
Soliman PT, Frumovitz M, Sun CC, dos Reis R, Schmeler KM, Nick AM, Westin SN, Brown J, Levenback CF, Ramirez PT. Radical Hysterectomy: A comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol 123(2):333-6, 2011. e-Pub 2011. PMID: 21872911.
Ramirez PT, Jhingran A, Macapinlac HA, Euscher ED, Munsell MF, Coleman RL, Soliman PT, Schmeler KM, Frumovitz M, Ramondetta LM. Laparoscopic extraperitoneal para-aotic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer 117(9):1928-34, 2011. e-Pub 2011. PMID: 21082702.
Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL Anderson ML, Ramondetta LR, Tortolero-Luna G, Urbauer DL, Chang S, Gershenson DM, Brown J, Lu KH. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Ob Gynecol 204(4):355, 2011. e-Pub 2011. PMID: 21324431.
Soliman PT, Cui X, Zhang Q, Handinson SE, Lu KH. Circulating adiponectin levels and risk of endometrial cancer: The prospective Nurses' Health Study. Am J Ob Gyn 204(2):167, 2011. e-Pub 2011. PMID: 21047616.
Nick AM, Lange J, Frumovitz, Soliman PT, Schmeler KM, Schlumbrecht MP dos Reis R, Ramirez PT. Rate of vaginal cuff separation following laparoscopic or robotic hysterectomy. Gynecol Oncol 120(1):47-51, 2011. e-Pub 2011. PMID: 20869763.
Westin SN, Sun CC, Lu KH, Schmeler KM, Soliman PT, Lacour RA, Johnson KG, Daniels MS, Arun BK, Peterson SK, Bodurka DC. Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma. Cancer 117(12):2659-67, 2011. e-Pub 2011. PMID: 21192063.
Ndofor B, Soliman PT, Schmeler KM, Nick AM, Frumovitz M, Ramirez PT. Rate of port-site metastasis is uncommon in patients undergoing robotic surgery for gynecological malignancies. Int J Gynecol Cancer 21(5):936-40, 2011. e-Pub 2011. PMID: 21633306.
Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifer PJ, Levenback CF, Ramirez PT. Primary malignant melanoma of the vagina. Obstet Gynecolo 116(6):1358-65, 2010. e-Pub 2010. PMID: 20837355.
Zand B, Euscher E, Soliman PT, Schmeler KM, Coleman RL, Frumovitz M, Jhingran A, Ramondetta LM, Ramirez PT. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. Gynecol Oncol 119(3):422-5, 2010. e-Pub 2010.
Soliman PT, Frumovitz M, Spannuth W, Greer MJ, Sharma S, Schmeler KM, Ramirez PT, Levenback CF, Ramondetta LM. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol 119(2):291-4, 2010. e-Pub 2010.
Ramirez PT, Schmeler KM, Malpica A, Soliman PT. Safety and feasibility of robotic radical trachelectomy in patients with early-stage cervical cancer. Gynecol Oncol 116(3):512-515, 2010. e-Pub 2010. PMID: 19944451.
Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer: Implications for survivors. Cancer 116(3):625-630, 2010. e-Pub 2010. PMID: 20052724.
Schmeler KM, Daniels MS, Soliman PT, Broaddus RR, Deavers MT, Vu TM, Chang GJ, Lu KH. Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch Syndrome. Obstet Gynecol 115(2 Pt 2):432-434, 2010. e-Pub 2010. PMID: 20093870.
Nick AM, Schmeler KM, Frumovitz MM, Soliman PT, Spannuth WA, Burzawa JK, Coleman RL, Wei C, dos Reis R, Ramirez PT. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surger. Obstet & Gynecol 116(4):956-61, 2010. e-Pub 2010. PMID: 20859161.
Mabrouk M, Frumovitz M, Greer M, Sharma S, Schmeler KM, Soliman PT, Ramirez PT. Trends in laparoscopic and robotic surgery among gynecologic oncologists: A survey update. Gynecol Oncol 112(3):501-505, 2009. e-Pub 2009. PMID: 19138793.
Jandial DD, Soliman PT, Slomovitz BM, Schmeler KM, Levenback C, Coleman RL, Ramirez PT. Laparoscopic colostomy in gynecologic cancer. J Minim Invasive Gynecol 15(6):723-8, 2008. e-Pub 2008. PMID: 18971136.
Frumovitz M, Soliman PT, Greer M, Schmeler KM, Moroney J, Bodurka DC, Ramirez PT. Laparoscopy training in gynecologic oncology fellowship programs. Gynecol Oncol 111(2):197-201, 2008. e-Pub 2008. PMID: 18804849.
Soliman PT, Bassett RL, Wilson EB, Boyd-Rogers S, Schmeler KM, Milam MR, Gershenson DM, Lu KH. Limited public knowledge of obesity and endometrial cancer risk: what women know. Obstet Gynecol 112(4):835-842, 2008. e-Pub 2008. PMID: 18827126.
Frumovitz M, Sun CC, Jhingran A, Schmeler KM, Dos Reis R, Milam MR, Soliman PT, Taylor K, Ramirez PT. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol 112(4):899-905, 2008. e-Pub 2008. PMID: 18827134.
Ramirez PT, Schmeler KM, Wolf JK, Brown J, Soliman PT. Robotic radical parametrectomy and pelvic lymphadenectomy in patients with invasive cervical cancer. Gynecol Oncol 111(1):18-21, 2008. e-Pub 2008. PMID: 18639329.
Obermair A, Gebski V, Frumovitz M, Soliman PT, Schmeler KM, Levenback C, Ramirez PT. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol 15(5):584-8, 2008. e-Pub 2008. PMID: 18722970.
Milam MR, Soliman PT, Chung LH, Schmeler KM, Bassett RL, Broaddus RR, Lu KH. Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia. Int J Gynecol Cancer 18(1):146-51, 2008. e-Pub 2008. PMID: 17466036.
Soliman PT, Lu K. Endometrial cancer associated with defective DNA mismatch repair. Obstet Gynecol Clin North Am 34(4):701-715, 2007. e-Pub 2007. PMID: 18061865.
Lu KH, Schorge JO, Rodabaugh KJ, Daniels MS, Sun CC, Soliman PT, White KG, Luthra R, Gershenson DM, Broaddus RR. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. J Clin Oncol 25(33):158-164, 2007. e-Pub 2007. PMID: 17925543.
Tung CS, Soliman PT, Wallace MJ, Wolf JK, Bodurka DC. Successful catheter-directed venous thrombolysis in phlegmasia cerulea dolens. Gynecol Oncol 107(1):140-142, 2007. e-Pub 2007. PMID: 17669477.
Milam MR, Celestino J, Wu W, Broaddus RR, Schmeler KM, Slomovitz BM, Soliman PT, Gershenson DM, Wang H, Ellenson LH, Lu KH. Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model. Am J Obstet Gynecol 196(3):247.e1-5, 2007. e-Pub 2007. PMID: 17346540.
Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Obstet Gynecol 108(3.1):515-520, 2006. e-Pub 2006. PMID: 16946209.
Slomovitz BM, Ramirez PT, Frumovitz M, Soliman PT, Bevers M, Coleman RL, Levenback C. Electrothermal bipolar coagulation for pelvic exenterations. Gynecol Oncol 102(3):534-536, 2006. e-Pub 2006. PMID: 16483643.
Ramirez PT, Slomovitz BM, Soliman PT, Coleman RL, Levenback C. Total laparoscopic radical hysterectomy and lymphadenectomy: The MD Anderson Cancer Center Experience. Gynecol Oncol 102(2):252-255, 2006. e-Pub 2006. PMID: 16472844.
Wu W, Slomovitz BM, Soliman PT, Schmeler KM, Celestino J, Milam MR, Lu KH. Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma. Int J Gynecol Cancer 16(4):1668-72, 2006. e-Pub 2006. PMID: 16884382.
Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gershenson DM, Lu KH. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106(11):2376-2381, 2006. e-Pub 2006. PMID: 16639730.
Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354(3):261-9, 2006. e-Pub 2006. PMID: 16421367.
Soliman PT, Broaddus RR, Schmeler KM, Daniels MS, Gonzalez D, Slomovitz BM, Gershenson DM, Lu KH. Women with synchronous primary cancers of the endometrium and ovary: Do they have lynch syndrome?. J Clin Oncol 23(36):9344-9350, 2005. e-Pub 2005. PMID: 16361634.
Schmeler KM, Soliman PT, Sun CC, Slomovitz BM, Gershenson DM, Lu KH. Endometrial cancer in young, normal-weight women. Gynecol Oncol 99(2):388-392, 2005. e-Pub 2005. PMID: 16051336.
Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 105(3):575-580, 2005. e-Pub 2005. PMID: 15738027.
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH. Her-2/neu overexpression and amplification in uterine papillary serous carcinoma. J Clin Oncol 22(15):3126-3132, 2004. e-Pub 2004. PMID: 15284264.

Invited Articles

Olawaiye, Alexander B, Miller, David S, Soliman, Pamela T. Outcomes in Older Women With Endometrial Cancer. Expert Perspectives® in Endometrial Cancer, 2023. e-Pub 2023.
Soliman, Pamela T. The Impact of Diabetes on Endometrial Cancer Risk and Prognosis. Expert Perspectives® in Endometrial Cancer, 2023. e-Pub 2023.
Miller, David S, Olawaiye, Alexander B, Soliman, Pamela T. Predictors of Long-term Survival in Endometrial Cancer. Expert Perspectives® in Endometrial Cancer, 2023. e-Pub 2023.
Soliman, Pamela T. Endometrial Cancer and Obesity. Expert Perspectives® in Endometrial Cancer, 2023. e-Pub 2023.
Miller, David S, Olawaiye, Alexander B, Soliman, Pamela T. State-of-the-Art Management of Advanced or Recurrent Endometrial Cancer. Expert Perspectives® in Endometrial Cancer, 2023. e-Pub 2023.
Soliman, Pamela T. Updates on Imaging in Newly Diagnosed Endometrial Cancer. Expert Perspectives® in Endometrial Cancer, 2023. e-Pub 2023.
Olawaiye, Alexander B, Miller, David S, Soliman, Pamela T. Immunotherapy in Endometrial Cancer: Current Progress and Future Directions. Expert Perspectives® in Endometrial Cancer, 2023. e-Pub 2023.
Ring KL, Yemelyanova AV, Soliman PT, Frumovitz MM, Jazaeri AA. Potential immunotherapy targets in recurrent cervical cancer. Gynecol Oncol. e-Pub 2017. PMID: 28233576.
Soliman PT. Prospective Surgical Trials in Gynecologic Cancer. AAGL NewsScope 28(1):5, 2014. e-Pub 2014.
Soliman PT. News from the SIGS-Current Staging for Endometrial Cancer. AAGL NewsScope 25(1):1-6, 2011. e-Pub 2011.
Soliman PT. Robotic Surgery in Gynecologic Oncology. AAGL NewsScope October-December, 2007. e-Pub 2007.
Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, Berenson A, Ramirez PT, Lu KH, Bodurka DC. Are women ready for the HPV vaccine?. Gynecol Oncol 103(1):151-154, 2006. e-Pub 2006. PMID: 16551476.
Soliman PT, Slomovitz BM, Wolf JK. Mechanisms of cervical Cancer. Drug Discovery Today: Disease Mechanisms 1:253-258, 2004. e-Pub 2004.

Review Articles

How, JA, Jazaeri, AA, Westin, SN, Lawson, BC, Klopp, AH, Soliman, PT, Lu, KH. Translating biological insights into improved management of endometrial cancer. Nature Reviews Clinical Oncology 21(11):781-800, 2024. e-Pub 2024. PMID: 39198622.
How JA, Frumovitz M, Stewart KI, Soliman PT. Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers. Curr Oncol Rep 24(11):1521-1529, 2022. e-Pub 2022. PMID: 35781863.
Maheshwari E, Nougaret S, Stein EB, Rauch GM, Hwang KP, Stafford RJ, Klopp AH, Soliman PT, Maturen KE, Rockall AG, Lee SI, Sadowski EA, Venkatesan AM. Update on MRI in Evaluation and Treatment of Endometrial Cancer. Radiographics 42(7):2112-2130, 2022. e-Pub 2022. PMID: 36018785.
Marchocki Z, Cusimano MC, Clarfield L, Kim SR, Fazelzad R, Espin-Garcia O, Bouchard-Fortier G, Rossi EC, Stewart KI, Soliman PT, How JA, Gotlieb WH, Holloway RW, Ianieri MM, Cabrera S, Lim YK, Ferguson SE. Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics. Am J Obstet Gynecol 225(4):367.e1-367.e39, 2021. e-Pub 2021. PMID: 34058168.
Hamilton CA, Pothuri B, Arend RC, Backes FJ, Gehrig PA, Soliman PT, Thompson JS, Urban RR, Burke WM. Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations. Gynecol Oncol 160(3):817-826, 2021. e-Pub 2021. PMID: 33516529.
Hamilton CA, Pothuri B, Arend RC, Backes FJ, Gehrig PA, Soliman PT, Thompson JS, Urban RR, Burke WM. Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II. Gynecol Oncol 160(3):827-834, 2021. e-Pub 2021. PMID: 33451724.
Fader AN, Huh WK, Kesterson J, Pothuri B, Wethington S, Wright JD, Bakkum-Gamez JN, Soliman PT, Sinno AK, Leitao M, Martino MA, Karam A, Rossi E, Brown J, Blank S, Burke W, Goff B, Yamada SD, Uppal S, Dowdy SC. When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 Pandemic. Gynecol Oncol 158(2):236-243, 2020. e-Pub 2020. PMID: 32532460.
Jazaeri A, Coleman RL, Sood AK, Frumovitz MM, Soliman PT, Shafer A, Cutrera JJ, Klinger M, Sharafi SE, Johnson CAL, Villanueva VF, Hinchcliff EM, Dickens A, Cain KE, Anderson JE, Lu KH, Westin SN. A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice. Gynecol Oncol 151(2):374-380, 2018. e-Pub 2018. PMID: 30213435.
Cox VL, Bhosale P, Varadhachary GR, Wagner-Bartak N, Glitza IC, Gold KA, Atkins JT, Soliman PT, Hong DS, Qayyum A. Cancer Genomics and Important Oncologic Mutations: A Contemporary Guide for Body Imagers. Radiology 283(2):314-340, 2017. e-Pub 2017. PMID: 28418819.
Darin MC, Gómez-Hidalgo NR, Westin SN, Soliman PT, Escobar PF, Frumovitz M, Ramirez PT. Role of indocyanine green (ICG) in sentinel node mapping in gynecologic cancer: Is fluorescence imaging the new standard?. J Minim Invasive Gynecol 23(2):186-93, 2016. e-Pub 2016. PMID: 26518716.
Ramirez PT, Soliman PT, Schmeler KM, dos Reis R, Frumovitz M. Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer. Gynecol Oncol 110(3 Suppl 2):S21-4, 2008. e-Pub 2008. PMID: 18486966.
Ramirez PT, Schmeler KM, Soliman PT, Frumovitz M. Fertility preservation in patients with early cervical cancer: radical trachelectomy. Gynecol Oncol 110(3 Suppl 2):S25-8, 2008. e-Pub 2008. PMID: 18501409.
Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu KH. Synchronous primary cancers of the endometrium and ovary: A single institution review of 84 cases. Gynecol Oncol 94(2):456-462, 2004. e-Pub 2004. PMID: 15297188.

Abstracts

Westin S, Litton JK, Williams RA, Shepherd CJ, Brugger W, Pease EJ, Soliman PT, Frumovitz MM, Levenback CF, Sood A, Meyer L, Moulder SL, Valero V, Saleem S, Rodriguez AM, Cyriac A, Engerman L, Samuel C, Mills GB, Coleman RL. Phase I trial of olaparib (PARP inhibitor) and vistusertib (mTORC1/2 inhibitor) in recurrent endometrial, ovarian and triple negative breast cancer. ASCO, 2018. e-Pub 2018.
Soliman PT. A cost-utility analysis of sentinel lymph node mapping, selective lymphadenectomy, and routing lymphadenectomy in the management of low-risk endometrial cancer. ASCO Quality Care Symposium(Abstract), 2017. e-Pub 2017.
Soliman PT. Sentinel lymph node mapping accurately identifies positive nodes in women with high risk endometrial cancer: A prospective validation trial. IGCS(Abstract), 2016. e-Pub 2016.
Soliman PT. Phase 2 study of everolimus, letrozole, and metformin in women with advanced/recurrent endometrial cancer. ASCO(Abstract #5506), 2016. e-Pub 2016.
Soliman PT, Nick AM, Sun CC, Diaun S, Pal N, Abdelwahab M, Frumovitz M, Ramirez PT, Lu KH, Westin SN. Obesity significantly reduces sentinel lymph node detection rate in women with endometrial cancer. SGO(Abstract), 2016. e-Pub 2016.
Soliman PT, Garcia EA, Lang KE, Villanueva V, Westin SN, Fleming ND, Feeley TW, Lu KH, Meyer L. Evaluation of resource utilization using time-derived,activity-based costing (TDABC) to result in more effective processes and cost reduction. ASCO Quality Care Symposium(Abstract #22), 2016. e-Pub 2016.
Khawaja MR, Madhusudanannair V, Ng C, Nick AM, Janku F, Piha-Paul S, Coleman RL, Soliman PT, Fu S, Hong D, Karp D, Subbiah V, Tsimberidou AM, Meric-Bernstam F, Lu KG, Naing A. Phase I Dose Escalation Study of Temsirolimus in Combination with Metformin in Patients with Advanced Cancers. 2015 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference, 2015. e-Pub 2015.
Ramirez PT, Schmeler K, Burzawa JK, Soliman PT, Westin SN, Munsell M, Frumovitz M, Hosaka M. Poster presentation: Lymphovascular Space Invasion Portends Poor Prognosis in Low and Intermediate Risk Endometrial Cancer. 15th Biennial Meeting of the International Gynecologic Cancer Society, Melbourne, Australia(IGCSM-0094), 2014. e-Pub 2014.
Prescott LS, Taylor JS, Bodurka D, Catallo RC, Dickens A, Garcia EA, Guerra SL, Kurian S, Levenback CF, Lewis-Patterson P, Lowe KB, Lozano G, Miguel A, McGilbra JP, Meadway JE, Patel D, Phillips DG, Soliman PT, Tanha J, Vanterpool JR, Villanueva VF, Warren RQ. SMART Chemotherapy: A Comprehensive Cancer Center's Journey to Shared Medical Appointments. The University of Texas System Shared Visions Conference, San Antonio, Texas(10/2014), 2014. e-Pub 2014.
Garcia EA, Bearden LJ, Daniels MS, Hubbs CA, Lang KE, Miller NR, Miremadi R, Ortega ML, Phillips G, Soliman PT, Lu KH. Poster presentation: Ovarian Cancer Moon Shot: Genetic Counseling Screening Process Improvement. The University of Texas M.D. Anderson Cancer Center, Celebrating Improvement Conference, Houston Texas(10/2014), 2014. e-Pub 2014.
Garcia EA, Bearden LJ, Daniels MS, Hubbs CA, Lang KE, Miller NR, Miremadi R, Ortega ML, Phillips G, Soliman PT, Lu KH. Poster presentation: Supporting the Ovarian Cancer Moon Shot: Genetic Counseling & Testing Process Improvement. CS&E Conference, San Antonio, Texas(10/2014), 2014. e-Pub 2014.
Soliman PT, Garcia E, Lang KE, Lewis-Patterson P, Levenback CF, Bodurka D. SMART Chemotherapy: A Comprehensive Cancer Center's Journey to Shared Medical Appointments. ASCO Quality Care Symposium, Poster Presentation, Boston, MA(Abstract #135), 2014. e-Pub 2014.
Nick AM, Ramirez PT, Rangel KM, Schmeler KM, Soliman PT, Burzawa JK, Kodama M, Lu KH, Coleman RL, Sood AK. Launching Personalized Surgical Therapy for Advanced Ovarian Cancer. SGO 45th Annual Meeting on Women's Cancer, 2014. e-Pub 2014.
Milam MR, Riley EC, Myers JA, Wilcox L, Soliman PT, Cummings S. Risk factors for uterine cancer in breast cancer survivors: An army of women study. ACOG 61st Annual Clinical Meeting, 2013. e-Pub 2013.
Holman L, Soliman PT, Pal N, Balakrishnan Klopp A, Broaddus R, Fleming N, Munsell M, Lu K, Westin S. Importance of platinum sensitivity and treatment modality in advanced-stage uterine papillary serous carcinoma. SGO 44th Annual Meeting on Women's Cancer, 2013. e-Pub 2013.
Holman L, Soliman PT, Pal N, Mhadgut H, Klopp A, Broaddus R, Fleming N, Munsell M, Lu K, Westin S. Neoadjuvant chemotherapy in stage IV uterine papillary serous carcinoma. SGO 44th Annual Meeting on Women's Cancer, 2013. e-Pub 2013.
Soliman PT, Sun CC, Westin SN, Fleming N, Schmeler K, Nick A, Ramirez PT. Improvement in quality of life after robotic surgery results in patient satisfaction. SGO 44th Annual Meeting on Women's Cancer, 2013. e-Pub 2013.
Caroll A, Ramirez P, Westin S, Soliman PT, Munsell M, Nick A, Schmeler K, Frumovitz M, Klopp A, Fleming N. Uterine adenosarcoma: A closer look at a rare disease. SGO 44th Annual Meeting on Women's Cancer, 2013. e-Pub 2013.
Bandyopdhyay J, Munsell M, Schmeler KM, Nick AM, Westin SN, Fleming N, Ramirez PT, Soliman PT. Risk factors associated with conversion to laparotomy in patients undergoing robotic surgery. 41st AAGL Global Congress of Minimally Invasive Gynecology, 2012. e-Pub 2012.
Meyer L, Schmeler K, Wallbillich JJ, Garcia E, Urbauer D, Soliman PT, Frumovitz M, Burke C, Bodurka D, Levenback C. Development and implementation of Pap test guidelines in a Gyn Oncology practice. UT Health Science Center Summer Institutes on Evidence-Based Quality Improvement, 2012. e-Pub 2012.
Stone RL, Schlumbrecht MP, Johnston TA, Iglesias D, Lu KH, Coleman RL, Soliman PT. Sweet Response: Hyperglycemia and hypertriglyceridemia as biomarkers of clinical benefit for everolimus in patients with recurrent endometrial cancer. SGO Winter Annual Meeting, 2012. e-Pub 2012.
Huang M, Westin S, Iglesias D, Fellman B, Urbauer D, Frumovitz M, Ramirez P, Soliman P. Surgical outcomes and disease recurrence following pelvic exenteration: Does age matter?. 43rd Annual Meeting of the Society of Gynecologic Oncology 125(Supp 1):77, 2012. e-Pub 2012.
Schmeler K, Langley G, Cain K, Munsell M, Ramirez P, Soliman P, Nick A, Frumovitz M, Garcia E, Levenback C. Reduction in venous thromboembolism (VTE) rates following the implementation of extended duration prophylasix for patients undergoing surgery for gynecologic malignancies. 43rd Annual Meeting of the Society of Gynecologic Oncology 125(Supp A):20, 2012. e-Pub 2012.
Worley M, Anwandter C dos Reis R, Sun C, Nick A, Frumovitz M, Soliman P Schmeler K, Levenback C, Ramirez P. Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery. 43rd Annual Meeting of the Society of Gynecologic Oncology 125(Supp 1):121, 2012. e-Pub 2012.
Iglesia D, Munsell M, Frumovitz M, Westin S, Nick A, Schmeler K, Ramirez P, Soliman P. Successful incorporation of robotic surgery into gynecologic oncology fellowship training. 43rd Annual Meeting of the Society of Gynecologic Oncology 125(Supp 1):125, 2012. e-Pub 2012.
Iglesias D, Westin S, Rallapalli V, Huang M, Fellman B, d U, Frumovitz M, Ramirez P, Soliman P. The effect of body mass index (BMI) on surgical outcomes and disease recurrence following pelvic exenteration. 43rd Annual Meeting of the Society of Gynecologic Oncology 125(Supp 1):125, 2012. e-Pub 2012.
Zand B, Nick A, Sangi-Haghpeykar H, Frumovitz M, Soliman P, Schmeler K, Ramirez P. Predictive risk factors for prolonged hospitalizations after gynecologic laparoscopic surgery. 42nd Annual Meeting of the Society of Gynecologic Oncologists, 2011. e-Pub 2011.
Nick A, Frumovitz M, Schmeler K, Soliman P, Ramirez P. Fertility-sparing surgery for treatment of early-stage cervical cancer: Open versus robotic radical trachelectomy. 42nd Annual Meeting of the Society of Gynecologic Oncologists, 2011. e-Pub 2011.
Meyer L, Schmeler K, Wallbilich J, Urbauer D, Soliman P, Frumvitz M, Burke C, Bodurka D, Levenback C. Clinical practice guidelines decrease unnecessary Pap tests in survivors of gynecologic malignancies. 42nd Annual Meeting of the Society of Gynecologic Oncologists, 2011. e-Pub 2011.
Soliman PT, Langley G, Reis D, R, Frumovitz M, Schmeler KM, Nick A, Ramirez PT. Postoperative analgesic and antiemetic requirements after minimally invasive surgery for early cervical cancer: Is the robot better?. Society of Gynecologic Oncologists Annual Meeting - March 6-9, 2011, 2011. e-Pub 2011.
Soliman PT, Frumovitz M, Spannuth W, Greer MJ, Schmeler KM, Ramirez PT, Levenback CF, Ramondetta LM. Lymph node evaluation as part of surgical staging for endometrial cancer: Practice patterns among SGO members. Annual Meeting of the Society of Gynecologic Oncologists, 2010. e-Pub 2010.
Nick AM, Lange J, Fumovitz M, Soliman PT, Schmeler KM, Schlumbrecht MP, dos Reis R, Ramirez PT. Rate of viginal cuff separation following laparoscopic or robotic hysterectomy. 41st Annual Meeting of the Society of Gynecologic Oncologists, 2010. e-Pub 2010.
Nick A, Schmeler K, Frumovitz M, Soliman P, Spannuth W, Burzawa J, dos Reis R, Ramirez P. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. 41st Annual Meeting of the Society of Gynecologic Oncologists, 2010. e-Pub 2010.
Worley, Jr MJ, Anwandter C, Sun CC, dos Reis R, Nick AM, Frumovitz M, Coleman RL, Soliman PT, Schmeler KM, Ramirz PT. Impact of surgeon volume on patient outcome in gynecologic laparoscopy. AAGL 39th Global Congress of Minimally Invasive Gynecology, 2010. e-Pub 2010.
Ramirez P, Jhingran A, Iyer R, Euscher E, Munsell M, Soliman P, Schmeler K, Gano J, Ramondetta L. Laparoscopic extraperitoneal paraaortic lymphadenectomy in loclly advanced cervical cancer. 41st Annual Meeting of the Society of Gynecological Oncologists, 2010. e-Pub 2010.
Nick A, Schmeler K, Frumovitz M, Soliman P, dos Reis R, Ramirez P. Impact of prior surgery number and location on intraoperative complications at the time of minimally invasive surgery. CPRIT Innovations in Cancer Prevention and Research Conference, 2010. e-Pub 2010.
Uppal S Frumovitz M, dos Reis R, Nick AM, Coleman RL, Soliman PT, Schmeler KM, Ramirez PT. Association of body mass index and time under anesthesia with laparoscopic surgical complications. AAGL 39th Global Congress of Minimally Invasive Gynecology, 2010. e-Pub 2010.
Zand B, Euscher ED, Soliman PT, Schmeler KM, Coleman RL, Jhingran A, Frumovitz M, Ramondetta LM, Ramirez PT. Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer. AAGL 39th Global Congress of Minimally Invasive Gynecology, 2010. e-Pub 2010.
Tabah RN, Soliman PT, Schmeler KM, Ramirez PT. Robotic port-site metastases in patients with gynecological malignancies. AAGL 39th Global Congress of Minimally Invasive Gynecology, 2010. e-Pub 2010.
Spannuth WA, Frumovitz M, Nick A, Mena GE, Soliman PT, dos Reis R, Schmeler KM, Ramirez PT. Impact of Smoking on Perioperative pulmonary complications in laparoscopic surgery. AAGL 39th Global Congerss of Minimally Invasive Gynecology, 2010. e-Pub 2010.
Burzawa J, Schmeler K, Soliman P, Lacour R, Meyer L, Bevers M, Frumovitz M, Pustilnik T, Brown J, Anderson M, Ramondetta L, Tortolero-Luna G, Gershenson D, Lu K. Prospective population-based evaluation of insulin resistance, polycystic ovary syndrom and metabolic syndrome in a cohort of patients with endometrial cancer. Society of Gynecologic Oncologists 37th Annual Meeting, 2009. e-Pub 2009.
Schmeler KM, Daniels MS, Soliman P, Broaddus RR, Deavers MT, thuy MV, Chang GJ, Lu KH. Primary peritoneal cancer following bilateral salpingo-oophorectomy in two patients with Lynch symdrom. The International Society for Gastrointestimal Hereditary Tumours 2009 Meeting, Dusseldorf, Germany, 2009. e-Pub 2009.
Soliman PT, Ramirez PT, Schmeler KM, Frumovitz M, Levenback CF, Milam MR. The learning curve with minimally invasive radical hysterectomy: Laparoscopy versus robotic assisted procedures. AAGL Global Congress, 2008. e-Pub 2008.
Ramirez PT, Soliman P, Pareja R, Schmeler KM. Macroscopic para-aortic metastasis in locally advanced cervical cancer with negative imaging. AAGL Global Congress, 2008. e-Pub 2008.
Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz MM, Bodurka DC, Sood AK. Pelvic Fractures following radiation therapy for cervical cancer: Implications for survivors. ASCO Annual Meeting, 2008. e-Pub 2008.
Schmeler KM, Milam M, Frumovitz M, dos Reis R, Bevers MW, Brown J, Soliman P, Levenback C, Ramirez PT. The use of a vessel-sealant device (LigaSure) compared with ultrasonic surgical instrumentation (Harmonic Ace) in radical hysterectomy for cervical cancer. AAGL 36th Annual Meeting, 2007. e-Pub 2007.
Ramirez PT, Schmeler KM, Soliman PT. Laparoscopic pelvic lymphadenectomy in an obese patient. AAGL 36th Annual Meeting, 2007. e-Pub 2007.
Lacour R, Urbauer D, Nongueras-Gonzalez G, Lu K, Westin S, Milam M, Loose D, Soliman P, Schmeler K, Wu W, Broaddus R, Nabilsi N. Molecular abnormalities in histologically normal endometrium of obese women. 38th Annual Meeting of the Society of Gynecologic Oncologists, 2007. e-Pub 2007.
Westin S, Sun C, Lu K, Schmeler K, Soliman P, White K, Daniels M, Arun B, Peterson S, Bodurka D. Management strategies for women at high risk for breast and ovarian cancer: Are women satisfied?. American Soceity of Clinical Oncology Annual Meeting, 2007. e-Pub 2007.
Soliman P, Bassett R, Boyd-Rogers S, Schmeller K, Slomovitz B, Gershenson D, Lu K. Knowledge of weight and endometrial concer risk: What women know. 38th Annual Meeting of the Society of Gynecologic Oncologists, 2007. e-Pub 2007.
Slomovitz B, Burke T, Lu K, Wolf J, Johnston T, Wu W, Celestino J, Schmeler K, Soliman P, Broaddus R, Walker C. Loss of PTEN expression associated with response to RAD001 (mTOR inhibitor) in patients with recurrent endometrial cancer: Translational evaulation from a phase II study. 38th Annual Meeting of the Society of Gynecologic Oncologists, 2007. e-Pub 2007.
Milam M, Celestino E, Slomovitz B, Schmeler K, Soliman P, Broaddus R, Gershenson D, Wu W, Ellenson L, Lu K. Reduced progression of endometrial hyperplasia in PTEN heterozygote mice treated with the oral mTOR inhibitor RAD001. Society of Gynecologic Oncologists 37th Annual Meeting, 2006. e-Pub 2006.
Soliman P, Tortolero-Luna G, Schmeler K, Milam M, Slomovitz B, Sun C, Brown J, Gershenson D, Lu K, Williams M, Betts P. Racial differences in survival among Texas women with endometrial cancer: A population-based study. Society of Gynecologic Oncologists 37th Annual Meeting, 2006. e-Pub 2006.
Soliman P, Morris V, Sun C, Ramirez P, Weaver C, Jennings J, Schmeler K, Slomovitz B, Bodurka D. No increase in risk associated with primary surgical cytoreduction in women diagnosed with ovarian cancer at an advanced age. Annual International Gynecologic Cancer Society Meeting, 2006. e-Pub 2006.
Soliman P, Schmeler K, Broaddus R, Slomovitz B, Wu W, Gershenson D, Lu K. MTOR inhibition as a potential treatment for progesterone refractory endometrial hyperplasia. American Society of Clinical Oncology Annual Meeting, 2006. e-Pub 2006.
Schmeler K, Sun C, Bodurka D, White K, Soliman P, Uyei A Erlichman J, Arun B, Peterson S, Milam M, Slomovitz B, Gershenson D, Lu K. Are Women with BRCA1/2 mutations choosing prophylactic bilateral salpingo-oophorectomy over surveillance?. Society of Gynecologic Oncologists 37th Annual Meeting, 2006. e-Pub 2006.
Milam M, Slomovitz B, Schmeler K, Soliman P, Ramirez P, Sun C, Eifel P, Ramondetta L, Lu K. Management and patterns of recurrence of women with Occult stage II endometriod endometrial cancer. Society of Gynecologic Oncologists 37th Annual Meeting, 2006. e-Pub 2006.
Schmeler K, Broaddus R, Sun C, Soliman P, Milam M, Thornton A, Wu W, Slomovitz B, Gershenson D, Lu K, McCampbell A, Shipley G. Obesity-related endometrial cancers are not molecularly distinct from endometrial cancers arising in normal-weight women. Society of Gynecologic Oncologists 37th Annual Meeting, 2006. e-Pub 2006.
Slomovitz B, Lu K, Burke T, Soliman P, Schmeler K, Munsell M, Johnston T Coleman R, Ramondetta L, Gershenson D, Wolf J. MTOR is a rational target for the treatment of endometrial cancer:Preliminary results of a phase II study of RAD001 for patients with recurrent endometrial cancer. Society of Gynecologic Oncologists 37th Annual Meeting, 2006. e-Pub 2006.
Soliman PT, Schmeler KM, Slomovitz BM, Peterson SK, Gershenson DM, Lu KH. Obesity and endometrial cancer risk: Are we counseling our patients appropriately?. American College of Obstetrics and Gynecology District VII/VIII Annual Meeting, 2005. e-Pub 2005.
Schmeler KM, Soliman PT, Munsell M, Daniels M, White K, Boyd-Rogers S, Sun CC, Slomovitz BM, Gershenson DM, Lu KH. Prophylactic surgery for the reduction of gynecologic cancer rish in women with lynch syndrome/HNPCC. Annual Meeting of the American Society of Clinical Oncology, 2005. e-Pub 2005.
Soliman PT, Schmeler KM, Broaddus RR, Slomovitz MM, Wu W, Gershenson DM, Lu KH. mTor Inhibition as a potential treatment for progesterone refractory endometrial hyperplasia. Annual Meeting of the American Society of Clinical Oncology, 2005. e-Pub 2005.
Schmeler K, Soliman PT, Sun CC, Oh J, Gershenson DM, Clomovitz BM, Lu KH. Defining endometrial cancer risk factors for young, non-obese women. Annual Meeting of the Society of Gynecologic Oncologists, 2005. e-Pub 2005.
Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomvitz BM, Gershenson DM, Lu KH. Adiponectin as a marker for insulin resistance and endometrial cancer risk. Annual Meeting of the Society of Gynecologic Oncologists, 2005. e-Pub 2005.
Slomovitz BM, Ramondetta LM, Crotzer D, Soliman PT, Schmeler KM, Broaddus RR, Sun CC, Gershenson DM, Burke TW, Lu KH. Clinical and pathologic review of clear cell carcinoma of the endometrium: A single institution study of 81 patients. Annual Meeting of the Society of Gynecologic Oncologists, 2005. e-Pub 2005.
Soliman PT, Broaddus RR, Schmeler KM, Gonzalez D, Slomvitz BM, Gershenson DM, Lu KH. Synchronous primary cancers of the endometrium and ovary: Do these women have HNPCC?. Annual Meeting of the Society of Gynecologic Oncologists, 2005. e-Pub 2005.
Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Pearson HC, Berenson A, Bodurka DC. Are women ready for the cervical cancer vaccine?. Annual Meeting of the Society of Gynecologic Oncologists, 2005. e-Pub 2005.
Slomovitz BM, Burke TW, Soliman PT, Ramondetta LM, Eifel PJ, Jhingran A, Wolf J, Sun CC, Gershenson DM, Lu KH. Patterns of recurrence of uterine papillary serous carcinoma. Annual Meeting of the Society of Gynecologic Oncologists, 2005. e-Pub 2005.
Schmeler K, Soliman PT, Sun CC, Oh J, Slomovitz BM, Lu KH. Risk factors for endometrial cancer in young, premenopausal, non-obese women. Third Annual American Association for Cancer Research International Conference, 2004. e-Pub 2004.
Soliman PT, Peterson SK, Watts B, Daniels M, Lynch PM, Lu KH. Gynecologic cancer risk and screening in Women with HNPCC. 10th Biennial International Gynecologic Cancer Society Meeting, 2004. e-Pub 2004.
Soliman PT, Wu D, Schmeler KM, Peterson SK, Lu KH. Obesity and endometrial cancer risk: What do somen know?. Third Annual American Association for Cancer Research International Conference, 2004. e-Pub 2004.
Nichols C, Soliman PT, Uno M, Mandolsesi G. Practitioner responsiveness to urinary complaints during annual examination. American College of Obstetrics and Gynecology Annual Meeting, 2004. e-Pub 2004.
Slomovitz BM, Ramirez PT, Bodurka DC, Sun CC, Oh JC, Diaz P, Broaddus RR, Soliman PT, Gershenson DM, Lu KH. Does Tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?. Annual Meeting of the Society of Gynecologic Oncologists, 2004. e-Pub 2004.
Slomovitz BM, Wu W, Broaddus RR, Soliman PT, Celestino J, Thornton A, Wolf J, Gershenson DM, Lu KH. Preclinical assessment of mTOR inhibition: Novel therapeutic target for the treatment of endometrial cancer. Annual Meeting of the Society of Gynecologic Oncologists, 2004. e-Pub 2004.
Slomovitz BM, Wu W, Soliman PT, Broaddus RR, Bodurka DC, Sun CC, Gershenson DM, Lu KH. Clinical and molecular characteristics of patients who develop breast cancer and uterine papillary serous cancer (UPSC). Annual Meeting of the Society of Gynecologic Oncologists, 2004. e-Pub 2004.
Oh JC, Slomovitz BM, Soliman PT, Shingran A, Lu KH. Endometrial cancer with ovarian involvement: Does it matter if it metastatic or dual primary?. Annual Meeting of the Society of Gynecologic Oncologists, 2004. e-Pub 2004.
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Tarco E, Sun CC, Wu W, Gershenson DM, Lu KH. Her-2/neu expression and amplification in uterine papillary serous carcinoma (UPSC). Annual Meeting of the Society of Gynecologic Oncologists, 2004. e-Pub 2004.
Schimp VL, Sun CC, Jennings J, Soliman PT, Bodurka DC. Bowel obstruction in ovarian cancer patients: Surgical versus medical therapy. Annual Meeting of the Society of Gynecologic Oncologists, 2004. e-Pub 2004.
Soliman PT, Slomovitz BM, Sun CC, Gershendon DM, Lu RH. Characteristics of patients with both colorectal and endometrial cancer. Annual Meeting of the Society of Gynecologic Oncologists, 2004. e-Pub 2004.
Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, Gershenson DM, Lu RH. Synchronous primary cancers of the endometrium and ovary: A single institution review of 75 cases. Annual Meeting of the Society of Gynecologic Oncologists, 2004. e-Pub 2004.
Soliman PT, Uno M, Mandolesi G, Nichols C. Urinary incontinence and depression in an inner city population. American College of Obstetrics and Gynecology District IV Annual Meeting, 2003. e-Pub 2003.
Soliman PT Slomovitz BM, Gershenson DM, Lu K. Characteristics of patients with a history of colorectal cancer who develop endometrial cancer. American Association for Cancer Research International Conference, 2003. e-Pub 2003.
Soliman PT, Jung-Yun Lee, Kosei Hasegawa, Byoung-Gie Kim, Barry Berman, Shiro Suzuki, Bradley Corr, Mayu Yunokawa, Douglas Orr, Noboru Yamamoto, David S. Miller, Alka A. Potdar, Jialing Shen, Lea Dutta, Jincao Wu, Jodi McKenzie, Vicky Makker. Clinical and biomarker results from E7386 study 102: Global dose-expansion cohort of E7386 + lenvatinib (LEN) in patients (pts) with advanced/recurrent endometrial cancer (aEC) that progressed on platinum-based chemotherapy (PBC) and an anti-PD-(L)1 immunotherapy (IO). European Society For Medical Oncology.

Book Chapters

Hinchcliff, EM, Lawson, BC, Ratan, R, Soliman, PT. Uterine leiomyosarcoma, 145-160, 2023.
Slomovitz BM, Soliman PT, Wolf JK. Gynecologic Cancers-Chapter 20. In: The MD Anderson Surgical Oncology Handbook. 5. Lippencott Williams & Wilkins, 2017.
Soliman PT, Lu KH. Neoplastic Diseases of the Uterus: Endometrial Hyperlasia, Endometrial Carcinoma, Sarcoma: Diagnosis and Management. In: Comprehensive Gynecology. 7th. Elsevier, 714-732, 2017.
Lu KH, Klopp AH, Soliman PT, Schmandt RE. Increased Adiposity and Endometrial Cancer Risk. In: Adipose Tissue and Cancer. Springer , NY, 53-70, 2013.
Soliman PT, Lu KH. Neoplastic Diseases of the Uterus: Endometrial Hyperlasia, Endometrial Carcinoma, Sarcoma: Diagnosis and Management. In: Comprehensive Gynecology. 6th. Elsevier Mosby, 713-730, 2012.
Lu KH, Iglesias DA, Huan M, Soliman PT, Djordjevic B. Endometrial Hyperplasia and Cancer. In: Gynecologic Oncology. In: Clinical Practice and Surgical Atlas. McGraw-Hill, 105-138, 2012.
Schmeler KM, Soliman PT, Bodurka DC. Reproductive Issues. In: Internal Medicine Care of Cancer Patients. B.C. Decker, Inc, 653-658, 2009.
Soliman PT, Schmeler KM, Bodurka DC. Sexual Function Issues. In: Internal Medicine Care of Cancer Patients. B.C. Decker, Inc, 647-652, 2009.
Slomovitz BM, Soliman PT, Wolf JK. Gynecologic Cancers-Chapter 20. In: The MD Anderson Surgical Oncology Handbook. 4. Lippencott Williams & Wilkins, 520-563, 2006.

Less

CV information above last modified February 03, 2026

Pamela T. Soliman, M.D., M.P.H.

About Dr. Soliman

In the News

What is chemoradiation?

Ovarian cancer symptoms: 4 things to know

What does ovarian cancer pain feel like?

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Other Articles

Abstracts

Book Chapters

Patient Reviews

Request an Appointment

Related Links

Endometrial (Uterine) Cancer

Gynecologic Oncology Center

Gynecologic Oncology & Reproductive Medicine Department

Surgery Division

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop MD Anderson

What is chemoradiation? 